rfhg_17247.1

Basic information about the TSS

---

TSS ID: rfhg_17247.1 TSS ID(Version3): hg_16345.1 Species: human Chr: chr1		Start: 186375131 End: 186375165 Strand: -
Source datasets	FANTOM5|PRJNA401781|PRJNA4843412|PRJNA615891|DRA013844 |PRJDB5282|PRJNA597322
Protocol	CAGE|RAMPAGE|NETCAGE|SLIC_CAGE|C1CAGE|STRIPE-seq
TSS cluster detected*	8

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	pELS,CTCF-bound (EH38D2252225,EH38E1405987)
Category:	pELS

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: Y00672:0 GeneID: 7175 HGNC/MGI_ID: HGNC:12017 UniProt_ID: Nearer transcript ids and distances: U69668:15 BC016514:-34 LF319896:58 MA555473:58 ENST00000367478.9:-88 NM_003292.3:-88 BC094764:-89 BC156389:102 ENST00000474852.1:-160 ENST00000613151.1:-160 X66397:-160 X63105:-160 LF319897:184 MA555474:184 view more...

Gene_name: translocated promoter region, nuclear basket protein Gene_symbol: TPR Gene_synonyms: Gene_source: HGNC:12017

TATA-Box annotation

---

Distance to TSS:	105
Nearest PromoterID:	NM_003292
Entrez ID:	7175
Nearest Unigene:	Hs.279640
Nearest Refseq:	NM_003292
Nearest Ensembl:	ENSG00000047410
Gene Name:	translocated promoter region, nuclear basket protein
Gene Alias:	-
Gene Type:	protein-coding
CpG%:	0.235294
GC%:	0.857143
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@TPR p2@TPR p3@TPR p4@TPR p5@TPR p6@TPR
Sample		p1@TPR	p2@TPR	p3@TPR	p4@TPR	p5@TPR	p6@TPR
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	25.91	18.90	7.99	0.58	0.00	0.58
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	28.53	17.80	5.66	1.42	0.00	0.40
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	29.51	18.33	7.14	1.93	0.00	0.39
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	27.24	14.55	8.11	0.83	0.00	0.42
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	23.62	17.77	7.20	0.67	0.00	0.67
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	25.20	17.25	6.78	0.39	0.00	0.78
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	32.90	22.66	10.24	0.44	0.00	0.65
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	32.46	16.47	6.54	0.48	0.00	0.48
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	31.63	20.73	5.34	1.50	0.21	1.07
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	59.12	45.21	6.38	1.16	0.00	1.74
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	60.23	37.59	8.49	1.21	0.00	4.04
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	62.20	41.06	4.47	1.22	0.00	1.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	16.93	12.41	4.51	1.13	0.00	0.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	16.54	10.22	5.71	1.50	0.00	0.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	18.44	14.93	5.71	1.10	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	16.10	11.07	5.28	0.25	0.25	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	14.41	10.27	4.59	0.66	0.44	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	13.08	13.08	5.06	0.84	0.42	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	18.13	9.60	3.73	2.13	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	13.69	10.53	3.91	2.11	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	16.71	12.03	6.28	1.34	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	14.50	8.46	4.14	1.73	0.00	0.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	15.12	8.40	6.33	1.03	0.26	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	14.56	10.92	6.55	0.97	0.49	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	15.74	13.16	4.90	1.29	0.26	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	13.61	10.44	5.70	1.27	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	11.54	10.99	4.95	1.65	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	19.10	10.84	7.78	1.18	0.00	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	14.21	9.37	4.68	1.94	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	15.20	10.86	3.80	2.71	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	15.28	9.84	5.23	1.05	0.21	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	11.33	8.21	4.88	1.95	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	14.56	8.86	5.28	1.90	0.00	0.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	15.17	9.73	4.45	1.81	0.33	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	14.40	8.04	3.93	0.19	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	15.71	11.31	5.56	0.96	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	15.33	10.83	5.11	1.43	0.00	0.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	13.10	8.26	3.63	0.60	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	13.78	12.15	5.40	0.54	0.27	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	14.16	12.48	4.32	1.68	0.00	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	12.00	10.82	4.71	1.41	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	15.66	9.95	4.25	1.76	0.15	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	14.76	12.44	5.48	2.11	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	16.26	11.54	5.07	0.52	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	19.88	13.65	4.22	2.01	0.40	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	20.24	12.10	6.28	2.09	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	14.15	14.39	4.56	1.44	0.24	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	15.20	11.03	4.77	1.49	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	18.67	12.69	4.79	1.44	0.00	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	15.37	10.72	4.25	1.42	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	16.40	12.91	7.99	0.61	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	19.79	15.12	7.34	0.89	0.44	0.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	363.80	237.87	69.96	27.98	0.00	27.98
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	18.10	12.07	6.39	1.77	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	17.23	10.94	5.63	0.99	0.00	0.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	68.79	46.14	10.07	4.19	0.84	0.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	24.80	19.29	5.97	3.21	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	22.36	21.72	4.54	0.65	0.00	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	26.34	13.17	2.89	1.28	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	21.06	9.74	5.66	2.20	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	21.86	21.86	5.64	2.12	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	14.58	16.26	4.49	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	31.05	21.50	3.98	1.59	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	21.07	13.25	3.74	1.02	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	25.67	20.15	4.55	1.30	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	17.39	16.68	3.19	0.71	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	307.11	242.46	80.82	16.16	0.00	32.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	339.59	157.95	39.49	15.79	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	15.11	9.26	2.93	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	14.38	16.86	4.96	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	10.79	14.54	1.41	0.47	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	17.22	11.26	4.31	0.99	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	18.56	15.16	4.02	1.55	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	16.51	17.43	3.67	0.00	0.31	0.61
Adipocyte - breast, donor1	11376-118A8	13.30	9.82	7.13	0.95	0.16	0.16
Adipocyte - breast, donor2	11327-117E4	12.19	6.42	5.13	1.12	0.16	0.00
Adipocyte - omental, donor1	11473-119C6	13.23	11.96	6.62	0.64	0.38	0.25
Adipocyte - omental, donor2	11474-119C7	2.99	1.49	1.49	0.00	0.00	0.00
Adipocyte - omental, donor3	11475-119C8	8.04	2.01	3.68	0.67	0.00	0.33
Adipocyte - perirenal, donor1	11476-119C9	5.10	1.91	4.47	0.00	0.00	0.00
Adipocyte - subcutaneous, donor1	11259-116F8	4.40	0.00	0.00	1.10	0.00	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	4.97	5.42	3.16	0.00	0.00	0.00
Adipocyte - subcutaneous, donor3	11408-118E4	7.12	4.87	2.43	0.17	0.17	0.17
Adipocyte differentiation, day04, donor1	13019-139D4	24.45	20.14	7.24	1.76	0.20	0.20
Adipocyte differentiation, day04, donor2	13022-139D7	24.71	18.53	4.12	1.03	0.26	0.26
Adipocyte differentiation, day04, donor3	13025-139E1	17.01	18.96	5.85	0.84	0.28	0.28
Adipocyte differentiation, day04, donor4	13028-139E4	38.21	24.10	8.82	4.11	0.00	0.00
Adipocyte differentiation, day08, donor1	13020-139D5	22.52	14.32	8.12	1.53	0.24	0.32
Adipocyte differentiation, day08, donor2	13023-139D8	19.69	9.36	6.46	0.97	0.32	0.32
Adipocyte differentiation, day08, donor3	13026-139E2	11.73	3.73	4.27	1.07	0.00	0.53
Adipocyte differentiation, day08, donor4	13029-139E5	19.48	11.69	8.90	0.56	0.00	0.00
Adipocyte differentiation, day12, donor1	13021-139D6	6.24	2.91	1.25	0.42	0.00	0.42
Adipocyte differentiation, day12, donor2	13024-139D9	10.55	7.53	5.53	0.25	0.25	0.00
Adipocyte differentiation, day12, donor3	13027-139E3	9.82	7.20	4.58	0.65	0.00	0.00
Adipocyte differentiation, day12, donor4	13030-139E6	10.35	10.35	7.31	0.61	0.91	0.61
Alveolar Epithelial Cells, donor1	11510-119G7	2.21	1.55	0.00	0.00	0.22	0.00
Alveolar Epithelial Cells, donor2	11590-120G6	0.36	0.72	1.08	0.00	0.36	0.36
Alveolar Epithelial Cells, donor3	11671-122G6	0.00	0.00	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	7.38	4.50	3.60	0.00	0.00	0.00
Amniotic Epithelial Cells, donor2	11613-122A2	3.35	5.02	1.67	0.00	0.00	1.67
Amniotic Epithelial Cells, donor3	11694-123A2	3.49	2.26	1.23	0.21	0.00	0.00
Anulus Pulposus Cell, donor1	11248-116E6	13.04	9.50	5.26	1.26	0.00	0.00
Anulus Pulposus Cell, donor2	11463-119B5	12.00	4.41	6.12	0.98	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	11.23	4.04	4.04	0.45	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	13.02	3.47	3.47	0.43	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	6.42	2.14	2.14	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	11.96	8.07	2.99	0.00	0.60	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	12.65	7.59	6.32	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	3.30	0.66	7.26	0.00	0.00	0.66
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	7.80	3.25	3.57	0.32	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	8.25	7.77	2.43	0.00	0.97	0.49
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	4.75	4.16	2.38	0.59	0.00	0.59
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	13.94	3.39	3.77	0.75	0.00	0.38
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	13.06	5.81	1.45	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	5.02	2.51	2.51	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	11.20	5.44	6.92	0.49	0.00	0.16
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	8.19	0.00	4.09	1.36	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	5.28	3.47	4.37	0.15	0.30	0.45
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	8.57	4.82	3.75	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	9.07	4.53	4.72	0.57	0.00	0.19
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	12.03	6.15	4.81	0.53	0.27	0.53
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	11.71	3.90	5.85	0.00	0.98	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	9.12	3.48	3.15	0.33	0.33	0.17
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	3.60	0.00	2.40	1.20	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	17.70	7.08	3.54	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	10.29	5.15	4.29	0.69	0.17	0.17
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	4.19	4.19	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	12.14	2.91	4.37	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	12.52	5.69	3.42	0.38	0.00	0.38
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	3.63	1.21	2.42	2.42	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	9.12	2.28	2.28	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	8.76	4.06	3.85	0.21	0.00	0.21
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	7.48	4.65	3.10	0.52	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	8.91	3.75	1.88	0.47	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	8.04	3.54	2.89	0.00	0.00	0.32
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	5.71	2.85	7.85	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	7.60	2.34	4.68	1.17	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	8.73	3.31	2.41	0.30	0.00	0.30
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	4.75	2.38	7.13	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	8.14	2.03	4.07	0.00	0.00	0.51
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	6.62	2.80	3.57	0.51	0.25	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	1.91	4.45	2.54	0.00	0.00	0.64
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	5.61	1.29	2.16	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	8.26	3.60	4.02	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	3.77	2.03	2.61	0.29	0.00	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	7.56	3.78	3.78	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	8.14	5.09	4.92	0.17	0.17	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	2.32	0.00	2.32	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	12.68	4.23	4.23	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	7.50	3.65	3.65	0.43	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	7.82	5.41	4.21	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	10.21	2.19	2.19	0.73	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	8.05	4.14	2.53	0.46	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	17.85	0.00	5.10	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	8.90	7.63	4.58	0.51	0.25	0.25
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	11.77	6.81	5.16	0.62	0.00	0.83
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	9.18	4.90	2.45	0.00	0.00	0.31
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	12.43	5.74	3.82	0.48	0.00	0.48
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	7.98	2.88	3.55	0.22	0.00	0.44
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	1.53	3.05	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	11.08	4.98	4.98	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	11.65	5.30	4.24	0.79	0.26	0.26
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	7.63	4.00	2.18	0.36	0.00	0.00
Astrocyte - cerebellum, donor1	11500-119F6	6.26	3.32	2.09	0.25	0.00	0.00
Astrocyte - cerebellum, donor2	11580-120F5	4.45	1.20	0.86	0.17	0.00	0.00
Astrocyte - cerebellum, donor3	11661-122F5	3.78	2.31	1.26	0.21	0.00	0.00
Astrocyte - cerebral cortex, donor1	11235-116D2	24.05	13.94	4.53	2.09	0.35	0.00
Astrocyte - cerebral cortex, donor2	11316-117D2	31.87	15.04	7.28	3.56	0.16	0.49
Astrocyte - cerebral cortex, donor3	11392-118C6	37.59	18.79	5.97	3.43	0.00	0.15
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	60.55	33.60	7.68	2.41	1.26	0.69
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	64.27	34.08	8.77	1.38	0.88	0.38
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	69.30	36.07	12.52	3.19	0.80	0.46
Basophils, donor1	12241-129G9	3.40	5.49	3.66	0.52	0.78	0.26
Basophils, donor2	12242-129H1	16.60	20.57	7.58	3.97	0.72	1.08
Basophils, donor3	12243-129H2	4.85	5.14	5.14	1.76	0.15	0.00
Bronchial Epithelial Cell, donor1	11511-119G8	0.86	1.08	1.08	0.22	0.00	0.00
Bronchial Epithelial Cell, donor2	11591-120G7	0.91	1.83	1.83	0.00	0.00	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	7.17	7.17	0.00	7.17	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	6.28	1.26	2.51	0.63	0.00	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	5.20	2.08	1.04	0.21	0.00	0.21
Bronchial Epithelial Cell, donor6	11461-119B3	3.22	2.30	1.61	0.00	0.00	0.00
Bronchial Epithelial Cell, donor7	11769-123I5	8.64	6.30	3.96	1.62	0.00	0.00
Burkitt's lymphoma cell line:DAUDI	10422-106C8	49.47	25.35	7.73	7.63	0.31	0.21
Burkitt's lymphoma cell line:RAJI	10476-106I8	74.06	40.99	8.15	8.62	1.16	0.47
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	27.18	15.99	9.59	6.08	0.00	0.00
CD133+ stem cells - cord blood derived, pool1	12223-129E9	72.39	41.37	20.68	10.34	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	21.42	14.65	18.03	2.25	0.56	0.56
CD14+ Monocytes, donor2	11305-117B9	13.55	13.55	18.75	1.86	0.56	0.19
CD14+ Monocytes, donor3	11381-118B4	11.42	13.17	13.17	2.20	0.66	0.22
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	23.21	22.93	12.45	2.26	1.13	0.57
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	26.16	17.82	17.06	0.76	1.90	0.00
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	28.60	17.75	16.44	3.29	0.33	0.99
CD14+ monocytes - mock treated, donor1	11863-125A9	14.02	14.45	16.33	1.88	0.00	0.29
CD14+ monocytes - mock treated, donor2	11873-125C1	13.58	18.10	10.86	0.91	0.30	0.00
CD14+ monocytes - mock treated, donor3	11883-125D2	22.74	20.61	23.93	0.95	0.47	0.00
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	13.22	8.70	14.06	0.33	0.00	0.17
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	11.59	8.83	15.18	2.21	0.00	0.55
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	15.37	13.14	14.38	0.99	0.25	0.25
CD14+ monocytes - treated with BCG, donor1	11860-125A6	8.62	6.85	11.36	0.39	0.00	0.20
CD14+ monocytes - treated with BCG, donor2	11870-125B7	12.46	12.11	11.22	0.71	0.00	0.36
CD14+ monocytes - treated with BCG, donor3	11880-125C8	16.54	16.32	16.76	1.52	0.00	0.65
CD14+ monocytes - treated with Candida, donor1	11868-125B5	11.24	8.66	14.75	0.23	0.00	0.00
CD14+ monocytes - treated with Candida, donor2	11878-125C6	10.56	12.67	14.26	1.06	0.00	0.00
CD14+ monocytes - treated with Candida, donor3	11888-125D7	11.09	6.66	17.75	0.00	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	9.97	12.94	14.43	0.89	0.59	0.15
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	9.18	7.98	15.76	0.60	0.00	0.20
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	17.28	15.20	19.78	1.87	0.00	0.21
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	10.75	9.84	12.13	0.69	0.23	0.46
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	15.61	17.64	16.74	1.58	0.00	0.45
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	12.66	10.91	13.97	1.75	0.44	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	15.60	13.72	13.18	0.81	0.27	0.27
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	16.57	16.40	13.96	1.05	0.35	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	15.15	14.73	15.57	1.68	0.42	0.00
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	11.39	8.45	17.82	0.37	0.00	0.37
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	11.98	13.03	15.85	0.70	0.00	0.35
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	15.79	14.92	18.43	0.88	0.00	0.44
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	8.89	6.80	14.65	0.00	0.00	0.17
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	10.41	6.69	10.41	0.00	0.00	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	15.30	14.87	13.80	0.86	0.65	0.65
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	7.78	9.01	11.47	0.41	0.00	0.41
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	12.75	18.08	19.01	0.70	0.00	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	14.38	14.15	17.17	0.46	0.23	0.00
CD14+CD16+ Monocytes, donor1	11789-124B7	15.91	13.95	16.57	1.09	0.00	0.22
CD14+CD16+ Monocytes, donor2	11801-124D1	12.01	6.93	11.09	1.15	0.23	0.23
CD14+CD16+ Monocytes, donor3	11912-125G4	11.70	10.83	9.53	1.52	0.00	0.00
CD14+CD16- Monocytes, donor1	11788-124B6	18.22	14.95	20.56	1.25	0.31	0.00
CD14+CD16- Monocytes, donor2	11799-124C8	15.72	11.53	17.99	0.35	0.00	0.00
CD14+CD16- Monocytes, donor3	11910-125G2	36.34	40.80	31.88	2.23	0.67	0.45
CD14-CD16+ Monocytes, donor1	11790-124B8	18.37	17.35	10.46	0.51	0.51	0.51
CD14-CD16+ Monocytes, donor2	11800-124C9	16.69	13.39	13.61	0.88	0.88	0.22
CD14-CD16+ Monocytes, donor3	11911-125G3	18.32	18.32	12.84	0.21	0.21	0.21
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	20.32	28.45	8.13	2.03	4.06	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	29.15	13.56	4.75	2.03	8.14	4.07
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	30.03	14.50	8.28	3.11	6.21	1.04
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	28.78	18.66	10.13	6.93	4.80	1.07
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	31.63	10.19	9.11	5.36	8.04	1.07
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	26.67	9.13	5.62	1.40	4.91	3.51
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	23.53	13.33	4.71	2.35	7.06	0.78
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	34.28	13.18	6.59	2.64	5.27	2.64
CD19+ B Cells, donor1	11544-120B5	14.79	16.44	7.40	4.93	3.29	1.64
CD19+ B Cells, donor2	11624-122B4	17.41	12.33	9.43	0.00	0.00	0.00
CD19+ B Cells, donor3	11705-123B4	26.25	17.16	6.56	3.03	3.03	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	46.47	44.04	15.76	6.06	0.81	0.40
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	36.75	25.17	6.79	1.60	0.00	0.80
CD34+ Progenitors, donor1	11545-120B6	36.15	17.07	5.02	5.02	0.00	0.00
CD34+ Progenitors, donor2	11625-122B5	24.72	14.61	16.85	2.81	0.00	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	38.70	14.28	9.02	6.39	0.00	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	37.43	20.07	10.60	4.96	0.00	0.45
CD4+ T Cells, donor1	11225-116C1	68.91	63.20	18.57	7.86	2.50	1.07
CD4+ T Cells, donor2	11306-117C1	52.05	45.93	14.70	6.74	2.45	2.45
CD4+ T Cells, donor3	11382-118B5	43.31	39.65	14.94	5.49	0.61	0.91
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	38.03	35.22	12.51	6.38	1.79	2.55
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	40.20	35.26	13.70	7.19	2.02	1.12
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	36.79	35.93	15.52	6.90	2.59	1.44
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	40.30	26.08	8.53	4.27	6.64	3.32
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	25.28	34.41	7.02	3.51	4.21	1.40
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	19.78	23.07	3.30	6.59	19.78	3.30
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	35.84	31.36	8.38	3.47	1.88	0.72
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	34.40	26.61	9.83	5.08	2.20	1.86
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	27.57	24.99	9.03	3.06	2.90	0.97
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	25.55	20.17	10.31	3.59	2.69	2.69
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	27.95	20.96	8.39	2.45	2.45	1.05
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	40.92	33.44	14.08	7.48	7.04	2.20
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	37.95	37.10	7.59	10.54	0.84	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	38.02	28.67	6.65	3.74	0.62	0.21
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	30.41	22.39	6.35	4.68	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	51.67	39.43	14.41	5.44	4.62	2.45
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	56.81	40.20	11.25	3.75	5.90	1.07
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	48.42	41.24	7.17	1.79	5.38	1.79
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	48.58	39.87	15.58	5.56	1.11	0.93
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	36.82	31.84	9.75	6.93	1.08	0.43
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	32.57	29.42	8.20	3.99	2.31	0.42
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	29.83	36.40	6.07	4.04	2.02	0.51
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	37.26	32.93	9.53	3.03	0.87	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	61.89	46.63	13.51	8.28	7.84	1.74
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	45.53	24.25	8.91	6.93	3.46	2.97
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	29.54	24.93	9.23	10.16	2.77	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	33.50	25.12	12.56	6.98	2.79	1.40
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	55.11	29.35	10.80	8.03	4.98	4.98
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	63.80	33.86	9.32	10.06	5.15	2.70
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	46.20	36.96	12.32	10.78	4.62	1.54
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	55.51	37.24	13.25	8.24	6.09	2.51
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	49.86	37.39	11.08	5.54	9.69	1.38
CD8+ T Cells, donor1	11226-116C2	35.69	39.61	9.49	8.18	3.27	1.64
CD8+ T Cells, donor2	11307-117C2	34.54	30.41	5.26	10.89	3.00	1.13
CD8+ T Cells, donor3	11383-118B6	45.95	34.34	9.09	5.55	4.04	0.76
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	13.08	10.09	3.44	0.46	0.23	0.00
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	17.49	12.22	3.59	0.24	0.00	0.24
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	17.24	13.95	1.37	0.55	0.00	0.00
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	17.71	10.81	3.90	0.00	0.00	0.00
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	18.00	11.52	2.88	0.24	0.00	0.00
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	16.60	15.01	1.59	0.45	0.00	0.23
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	18.47	17.17	4.13	0.65	0.00	0.00
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	18.69	15.79	4.74	0.26	0.00	0.00
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	22.98	19.23	2.58	0.00	0.00	0.23
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	20.53	15.40	6.34	0.00	0.00	0.91
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	22.37	15.11	3.20	0.87	0.00	0.58
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	23.98	12.26	3.46	0.80	0.00	0.80
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	21.89	18.39	3.94	0.44	0.00	0.88
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	24.14	21.86	5.01	0.46	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	24.61	20.88	2.24	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	15.49	12.25	2.52	0.00	0.00	0.36
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	13.81	12.37	2.59	0.58	0.00	0.58
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	14.14	12.73	2.12	0.00	0.00	0.47
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	30.11	19.01	3.49	0.32	0.00	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	23.07	17.84	1.85	0.31	0.00	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	27.89	15.07	2.89	0.96	0.00	0.32
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	22.18	19.12	2.29	0.38	0.00	0.76
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	18.52	16.55	3.55	0.79	0.00	0.39
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	18.91	23.45	1.51	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	48.98	28.10	4.01	0.00	0.00	0.80
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	37.07	27.28	3.50	3.50	0.00	1.40
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	64.11	25.04	5.01	2.00	0.00	3.01
Cardiac Myocyte, donor1	11525-119I4	7.31	9.14	5.48	1.83	0.00	0.00
Cardiac Myocyte, donor2	11605-120I3	10.38	7.91	4.45	0.00	0.00	0.99
Cardiac Myocyte, donor3	11686-122I3	14.63	8.52	3.37	0.63	0.00	0.00
Chondrocyte - de diff, donor1	11261-116G1	19.07	13.87	7.63	2.08	0.00	0.35
Chondrocyte - de diff, donor2	11338-117F6	4.62	2.13	5.69	0.00	0.00	0.00
Chondrocyte - de diff, donor3	11410-118E6	10.81	7.40	4.44	0.57	0.46	0.34
Chondrocyte - re diff, donor2	11339-117F7	5.37	8.95	1.79	0.90	0.00	0.90
Chondrocyte - re diff, donor3	11411-118E7	6.87	8.09	5.26	1.21	0.00	0.81
Ciliary Epithelial Cells, donor1	11242-116D9	42.35	20.54	15.49	3.44	0.11	0.57
Ciliary Epithelial Cells, donor2	11323-117D9	23.73	11.54	9.19	0.43	0.21	0.21
Ciliary Epithelial Cells, donor3	11399-118D4	23.01	12.39	10.97	2.30	0.09	0.35
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	10.91	6.14	23.29	1.56	0.00	0.37
Corneal Epithelial Cells, donor1	11526-119I5	0.88	0.88	1.32	0.00	0.00	0.00
Corneal Epithelial Cells, donor2	11606-120I4	5.69	4.55	2.28	0.00	0.00	0.00
Corneal Epithelial Cells, donor3	11687-122I4	2.81	3.32	1.53	0.26	0.00	0.00
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	15.52	14.53	18.16	0.83	0.00	0.00
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	21.13	16.72	11.67	0.95	0.00	0.63
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	24.15	10.35	3.45	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	11.01	9.83	8.96	0.43	0.11	0.22
Dendritic Cells - plasmacytoid, donor1	11228-116C4	29.04	21.87	11.62	3.42	0.00	0.00
Dendritic Cells - plasmacytoid, donor2	11309-117C4	33.95	35.91	8.49	4.57	0.00	0.00
Dendritic Cells - plasmacytoid, donor3	11385-118B8	37.26	16.94	8.71	3.87	0.48	0.48
Endothelial Cells - Aortic, donor0	11207-116A1	7.84	4.50	1.83	0.67	0.00	0.00
Endothelial Cells - Aortic, donor1	11263-116G3	9.98	2.35	0.59	0.00	0.00	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	3.11	1.13	0.28	0.00	0.00	0.28
Endothelial Cells - Aortic, donor3	11412-118E8	6.29	4.33	1.18	0.79	0.00	0.00
Endothelial Cells - Artery, donor1	11264-116G4	5.82	2.91	1.16	0.87	0.00	0.00
Endothelial Cells - Artery, donor2	11341-117F9	18.82	12.71	5.65	1.18	0.24	0.00
Endothelial Cells - Artery, donor3	11413-118E9	7.71	5.26	1.93	0.35	0.00	0.35
Endothelial Cells - Lymphatic, donor1	11236-116D3	21.28	12.19	7.31	1.77	0.44	0.66
Endothelial Cells - Lymphatic, donor2	11317-117D3	24.95	14.00	8.52	2.43	0.61	0.00
Endothelial Cells - Lymphatic, donor3	11393-118C7	31.86	15.22	13.25	2.82	0.28	0.56
Endothelial Cells - Microvascular, donor1	11265-116G5	4.46	2.08	2.08	0.00	0.00	0.00
Endothelial Cells - Microvascular, donor2	11342-117G1	10.41	4.69	3.12	0.00	0.00	0.00
Endothelial Cells - Microvascular, donor3	11414-118F1	5.81	2.84	1.13	0.14	0.00	0.28
Endothelial Cells - Thoracic, donor1	11266-116G6	30.81	11.20	7.60	0.40	0.00	0.40
Endothelial Cells - Thoracic, donor2	11343-117G2	5.24	4.19	2.62	0.00	0.00	0.00
Endothelial Cells - Umbilical vein, donor1	11243-116E1	56.66	28.45	21.37	3.73	0.62	0.75
Endothelial Cells - Umbilical vein, donor2	11324-117E1	48.67	17.60	12.38	3.26	0.43	0.43
Endothelial Cells - Umbilical vein, donor3	11400-118D5	53.13	23.81	14.53	2.32	0.49	0.61
Endothelial Cells - Vein, donor1	11267-116G7	14.79	3.41	1.14	1.14	0.00	0.00
Endothelial Cells - Vein, donor2	11344-117G3	11.18	5.59	2.10	0.70	0.00	0.70
Endothelial Cells - Vein, donor3	11416-118F3	9.58	6.12	3.77	1.57	0.00	0.00
Eosinophils, donor1	12244-129H3	30.49	30.49	0.00	15.25	0.00	0.00
Eosinophils, donor2	12245-129H4	90.76	82.51	28.05	4.95	6.60	1.65
Eosinophils, donor3	12246-129H5	60.64	67.77	10.70	0.00	3.57	7.13
Esophageal Epithelial Cells, donor1	11507-119G4	0.73	2.20	0.49	0.00	0.00	0.24
Esophageal Epithelial Cells, donor2	11587-120G3	2.08	4.16	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	0.00	0.00	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	15.60	12.73	3.69	0.82	0.00	0.00
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	3.07	1.64	1.53	0.11	0.00	0.00
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	4.98	2.38	3.25	0.22	0.00	0.00
Fibroblast - Aortic Adventitial, donor1	11245-116E3	19.40	11.76	8.49	0.73	0.00	0.36
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	45.99	28.11	18.70	0.55	0.96	0.96
Fibroblast - Aortic Adventitial, donor2	11326-117E3	10.44	6.86	4.54	0.11	0.11	0.00
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	42.16	23.71	11.33	1.58	0.26	1.58
Fibroblast - Aortic Adventitial, donor3	11401-118D6	17.27	7.97	5.65	0.33	0.00	0.33
Fibroblast - Cardiac, donor1	11268-116G8	6.80	3.18	3.18	0.00	0.00	0.00
Fibroblast - Cardiac, donor2	11345-117G4	12.89	7.58	1.52	0.00	0.00	0.00
Fibroblast - Cardiac, donor3	11417-118F4	8.99	5.84	3.31	0.00	0.32	0.00
Fibroblast - Cardiac, donor4	11452-119A3	41.22	24.55	17.58	4.85	0.00	0.30
Fibroblast - Cardiac, donor5	11456-119A7	25.13	12.94	8.12	1.78	0.00	0.38
Fibroblast - Cardiac, donor6	11460-119B2	28.80	8.94	7.58	2.58	0.15	0.91
Fibroblast - Choroid Plexus, donor1	11492-119E7	7.77	2.01	3.48	0.40	0.00	0.13
Fibroblast - Choroid Plexus, donor2	11572-120E6	10.79	9.49	12.08	0.43	0.00	0.00
Fibroblast - Choroid Plexus, donor3	11653-122E6	27.83	10.25	5.86	0.00	0.00	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	7.84	3.00	3.92	0.46	0.00	0.00
Fibroblast - Conjunctival, donor3	11692-122I9	19.84	12.38	9.50	3.90	0.00	0.00
Fibroblast - Dermal, donor1	11269-116G9	8.92	8.69	7.04	0.00	0.23	0.00
Fibroblast - Dermal, donor2	11346-117G5	5.66	2.83	2.36	0.00	0.00	0.00
Fibroblast - Dermal, donor3	11418-118F5	10.40	7.74	6.04	0.36	0.00	0.00
Fibroblast - Dermal, donor4	11450-119A1	26.11	10.74	6.56	0.34	0.11	0.23
Fibroblast - Dermal, donor5	11454-119A5	24.25	12.04	6.28	0.17	0.00	0.35
Fibroblast - Dermal, donor6	11458-119A9	25.99	15.59	5.52	0.49	0.16	0.65
Fibroblast - Gingival, donor1	11237-116D4	25.82	15.41	7.91	1.46	0.42	0.00
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	35.89	20.44	7.34	1.05	0.00	0.26
Fibroblast - Gingival, donor2	11318-117D4	24.64	14.10	6.72	1.05	0.00	0.26
Fibroblast - Gingival, donor3	11394-118C8	27.94	15.95	6.96	1.45	0.29	0.10
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	27.01	13.51	4.16	1.04	0.00	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	13.22	8.63	4.58	1.06	0.00	0.00
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	36.79	21.20	6.55	1.40	0.16	0.16
Fibroblast - Gingival, donor6 (control)	11922-125H5	26.37	13.93	5.81	1.08	0.27	0.27
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	6.00	5.29	5.29	0.00	0.00	0.00
Fibroblast - Gingival, donor7 (control)	11924-125H7	25.15	17.99	7.46	0.44	0.00	0.29
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	35.45	21.41	7.77	1.77	0.00	0.00
Fibroblast - Gingival, donor8 (control)	11926-125H9	42.89	22.49	7.68	0.55	0.22	0.77
Fibroblast - Gingival, donor9 (control)	11927-125I1	35.07	20.54	8.36	1.91	0.44	0.15
Fibroblast - Lung, donor1	11270-116H1	4.08	1.36	1.36	0.00	0.00	0.00
Fibroblast - Lung, donor2	11347-117G6	29.84	13.43	5.97	2.98	0.00	1.49
Fibroblast - Lung, donor3	11419-118F6	13.93	7.60	5.28	0.63	0.00	0.00
Fibroblast - Lymphatic, donor1	11506-119G3	5.00	1.67	2.50	0.00	0.00	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	0.00	1.40	1.40	0.00	0.00	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	0.56	0.28	0.84	0.00	0.00	0.00
Fibroblast - Mammary, donor1	11540-120B1	4.06	4.87	0.81	0.00	0.00	0.00
Fibroblast - Mammary, donor2	11620-122A9	0.00	3.99	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	5.96	0.00	0.00	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	31.04	12.03	5.43	0.58	0.00	0.00
Fibroblast - Periodontal Ligament, donor2	11319-117D5	47.48	25.18	9.40	1.37	0.15	0.76
Fibroblast - Periodontal Ligament, donor3	11395-118C9	44.37	28.15	12.55	1.22	0.00	0.61
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	19.08	10.30	4.96	1.53	0.00	0.00
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	12.15	7.29	5.67	0.81	0.27	0.00
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	17.16	12.76	5.68	1.86	0.12	0.12
Fibroblast - Pulmonary Artery, donor1	11250-116E8	14.48	7.18	4.64	0.55	0.00	0.11
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	4.47	1.83	1.83	0.41	0.00	0.00
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	0.67	3.34	0.67	0.00	0.00	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	13.44	1.98	1.19	0.00	0.00	0.00
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	82.55	29.57	10.91	1.39	0.20	1.19
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	14.03	11.01	5.86	1.42	0.00	0.00
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	19.91	15.57	7.10	0.99	0.00	0.39
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	41.52	22.56	8.12	0.30	0.00	1.81
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	22.67	12.85	7.45	0.76	0.11	0.43
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	41.00	20.75	11.89	3.29	0.25	0.00
Fibroblast - skin normal, donor1	11553-120C5	13.95	7.71	3.45	0.98	0.00	0.16
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	87.62	46.12	16.04	4.01	0.80	0.80
Fibroblast - skin normal, donor2	11561-120D4	18.79	10.35	5.32	0.40	0.30	0.10
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	73.14	35.06	15.41	3.63	0.00	2.12
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	17.65	15.08	6.21	0.99	0.08	0.17
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	19.32	10.26	9.74	2.56	0.00	0.51
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	40.73	16.42	12.81	2.63	0.00	0.66
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	18.53	6.71	6.18	0.43	0.11	0.21
Fibroblast - skin walker warburg, donor1	11554-120C6	8.60	4.55	2.02	0.17	0.00	0.00
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	3.14	2.35	1.57	0.31	0.00	0.16
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	110.80	132.96	22.16	0.00	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	27.89	27.89	16.56	6.10	0.87	0.00
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	9.01	12.14	5.03	0.00	0.00	0.00
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	16.40	12.23	9.63	0.00	0.26	0.26
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	20.70	17.12	8.69	1.28	0.00	0.51
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	8.42	4.59	4.59	1.53	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	8.29	5.74	7.66	1.28	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	48.78	16.55	9.70	2.57	0.29	0.57
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	31.71	11.58	13.51	8.00	0.00	0.83
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	45.89	15.30	5.71	4.34	0.23	0.46
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	36.85	15.45	8.52	2.97	0.79	0.40
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	30.93	8.99	9.25	6.34	0.53	0.26
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	58.38	18.59	6.85	4.89	0.00	0.33
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	30.51	14.15	8.40	1.77	0.44	1.77
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	26.57	7.63	8.76	7.77	0.28	0.28
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	29.18	8.99	10.71	5.17	0.00	0.37
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	22.83	9.13	8.06	6.72	0.27	0.00
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	28.62	8.30	6.44	3.84	0.37	0.12
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	30.59	8.72	5.40	3.88	0.28	0.14
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	30.50	9.35	6.30	3.25	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	24.87	7.76	7.07	2.97	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	29.77	8.35	6.85	4.61	0.25	0.37
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	37.81	11.37	6.56	2.62	0.22	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	24.52	11.23	8.57	4.43	0.00	0.59
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	35.77	9.54	9.86	5.25	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	27.03	10.50	9.83	3.13	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	25.61	8.47	9.68	5.44	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	40.21	8.82	8.48	3.90	1.02	0.51
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	38.57	19.24	12.77	6.12	0.18	0.53
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	39.44	14.05	16.65	7.08	0.31	0.21
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	33.30	9.91	11.95	7.17	0.17	0.17
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	31.98	6.20	8.52	3.76	0.44	0.44
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	33.86	17.06	10.82	5.41	0.25	0.25
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	36.75	17.15	11.43	6.74	0.41	0.61
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	24.76	7.84	8.66	3.71	0.21	0.62
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	32.28	8.65	7.96	4.84	0.23	0.46
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	29.02	10.34	7.17	4.34	0.00	0.50
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	22.70	8.38	8.38	1.76	0.00	0.22
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	24.48	7.13	10.21	4.80	0.37	0.12
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	32.26	11.02	8.10	4.21	0.49	0.81
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	23.73	13.15	6.74	3.85	0.32	0.00
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	26.63	6.25	7.39	3.41	0.38	0.09
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	21.35	9.02	4.27	4.43	0.00	0.32
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	26.76	7.91	8.51	2.43	0.00	0.61
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	26.66	8.78	7.53	3.87	0.10	0.31
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	18.66	7.46	5.93	3.29	0.00	0.22
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	22.44	10.94	5.89	2.24	0.00	0.56
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	31.76	9.63	5.28	3.89	0.09	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	21.12	7.75	3.74	1.34	0.27	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	24.02	11.63	5.36	3.06	0.00	0.31
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	20.08	6.09	3.89	3.24	0.00	0.13
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	19.25	10.30	6.78	2.71	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	22.86	10.88	6.82	2.58	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	22.15	10.97	6.80	2.19	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	30.74	13.88	8.93	0.99	0.99	0.99
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	18.47	11.74	3.96	2.77	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	20.38	12.51	3.83	2.42	0.20	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	34.31	20.84	13.72	8.13	0.76	0.25
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	44.99	14.73	17.32	9.55	0.00	0.20
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	32.97	7.86	11.40	7.55	0.15	0.15
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	57.28	13.50	13.91	8.80	0.00	0.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	9.70	5.95	2.19	4.38	0.31	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	7.91	3.96	2.54	3.11	0.28	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	28.59	15.22	8.30	10.15	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	34.65	7.42	4.95	9.90	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	26.69	14.70	6.19	8.51	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	14.44	12.84	6.42	6.42	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	29.56	19.13	26.08	10.43	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	25.39	13.67	8.46	10.42	0.00	0.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	38.71	15.65	9.06	9.88	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	36.65	26.66	3.33	3.33	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	31.32	13.98	6.99	6.15	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	25.17	14.05	12.75	6.21	0.00	0.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	33.55	15.10	7.55	9.23	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	35.62	10.18	11.77	7.32	0.32	0.32
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	21.40	10.87	7.81	6.79	0.68	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	22.97	12.53	6.26	14.62	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	26.92	6.87	9.74	4.01	0.57	0.57
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	10.66	3.55	4.74	0.89	0.00	0.30
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	32.19	13.55	1.69	8.47	0.00	1.69
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	42.25	16.57	7.87	7.04	0.41	1.24
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	29.92	9.90	10.13	9.67	0.23	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	10.54	10.54	21.07	5.27	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	22.68	11.15	8.46	6.54	0.77	0.38
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	22.49	11.41	5.22	6.52	0.33	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	15.38	8.03	3.34	6.02	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	24.66	6.16	8.48	7.71	0.00	0.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	25.68	10.27	12.67	6.50	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	17.39	7.45	4.97	14.91	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	21.23	8.49	14.16	8.49	0.47	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	18.10	12.67	3.62	6.03	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	23.91	7.63	7.63	8.14	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	24.73	12.76	11.17	10.77	0.40	0.80
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	42.92	10.85	5.92	13.81	0.00	0.49
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	36.59	11.80	15.35	11.80	0.00	1.18
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	19.25	8.17	9.34	8.17	0.58	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	32.04	7.90	6.58	7.46	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	20.34	5.09	5.93	6.78	0.00	0.85
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	10.74	5.37	3.58	7.16	0.00	0.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	16.50	9.22	6.79	4.85	0.49	0.00
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	2.28	2.28	2.28	0.00	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	13.72	8.73	5.82	0.42	0.00	0.42
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	3.37	5.62	1.12	0.00	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	13.32	10.47	5.39	0.63	0.00	0.32
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	4.60	4.60	2.51	0.42	0.00	0.00
Hep-2 cells mock treated, biol_rep1	11898-125E8	23.79	12.65	7.89	0.70	0.23	0.70
Hep-2 cells mock treated, biol_rep2	11899-125E9	28.87	16.88	10.47	0.51	0.34	0.68
Hep-2 cells mock treated, biol_rep3	11900-125F1	21.84	18.43	6.83	2.28	0.00	0.23
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	26.45	13.77	7.43	0.22	0.00	0.33
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	29.66	13.75	7.52	0.86	0.00	0.21
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	27.13	16.79	9.26	1.29	0.00	0.65
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	21.67	10.71	4.98	0.12	0.25	0.37
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	17.33	14.07	4.97	0.51	0.34	0.34
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	19.54	12.81	9.61	0.00	0.00	0.32
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	3.36	1.12	1.68	0.00	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	3.46	0.43	0.43	0.43	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	13.22	13.22	5.29	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	2.82	2.12	1.41	0.71	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	3.63	0.00	2.91	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	11.54	6.29	2.45	0.70	0.00	0.17
Hepatocyte, donor1	11523-119I2	31.48	18.16	12.11	0.00	0.00	0.00
Hepatocyte, donor2	11603-120I1	11.85	20.47	10.77	1.08	0.00	1.08
Hepatocyte, donor3	11684-122I1	25.77	17.79	6.75	0.00	1.23	0.00
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	44.38	35.90	5.22	11.75	0.00	0.65
Intestinal epithelial cells (polarized), donor1	11246-116E4	30.24	23.25	6.99	2.97	0.87	0.70
Iris Pigment Epithelial Cells, donor1	11530-119I9	17.15	8.10	4.53	0.41	0.14	0.55
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	9.55	9.55	3.18	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	13.35	26.70	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	81.25	27.08	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	11.08	12.46	2.77	0.00	1.38	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	12.51	12.51	2.50	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	23.74	47.47	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	15.38	15.38	2.56	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	9.14	18.28	4.57	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	27.61	19.49	0.00	0.00	0.00	1.62
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	6.67	8.34	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	3.63	25.41	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	22.50	13.23	3.97	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	13.30	15.52	2.22	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	10.48	10.48	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	15.12	10.08	3.78	0.00	0.00	0.63
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	20.11	6.19	1.55	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	14.63	14.63	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	14.21	5.81	1.94	0.00	0.00	0.65
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	12.88	14.49	4.83	0.00	0.00	1.61
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	0.00	11.95	23.90	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	22.00	8.15	3.26	0.00	0.81	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	10.92	9.24	3.78	0.42	0.00	0.42
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	28.74	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	12.86	8.84	6.43	0.00	0.80	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	6.46	11.08	1.85	0.92	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	30.16	45.24	15.08	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	12.27	7.55	0.94	0.47	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	10.88	11.79	2.72	0.91	0.00	0.91
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	58.97	14.74	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	19.37	15.07	3.23	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	13.98	3.81	1.27	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	16.43	32.86	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	17.86	10.20	3.19	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	14.58	14.58	0.00	3.65	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	0.00	15.80	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	16.42	7.14	1.43	2.14	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	26.55	6.64	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	0.00	0.00	20.85	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	14.51	5.56	0.31	0.93	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	19.32	8.78	0.00	1.76	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	18.86	6.29	9.43	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	25.73	11.82	2.09	0.70	0.00	0.70
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	4.43	13.28	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	9.73	16.21	6.48	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	19.18	9.59	3.49	0.00	0.87	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	18.00	20.25	2.25	0.00	2.25	2.25
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	20.91	6.97	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	9.60	3.20	0.00	1.07	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	11.08	4.16	2.77	1.39	0.00	1.39
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	22.80	11.40	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	23.01	5.52	2.76	0.92	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	18.15	12.10	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	6.21	12.42	0.00	6.21	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	10.57	3.17	3.17	0.00	0.00	0.00
Keratinocyte - epidermal, donor1	11272-116H3	8.89	8.08	8.24	0.24	0.24	0.16
Keratinocyte - epidermal, donor2	11349-117G8	1.17	1.76	1.76	0.00	0.00	0.00
Keratinocyte - epidermal, donor3	11421-118F8	17.61	9.84	5.49	0.00	0.09	0.19
Keratinocyte - oral, donor1	11251-116E9	22.48	13.85	10.44	2.84	0.11	0.00
Keratocytes, donor1	11527-119I6	6.88	3.78	0.00	0.69	0.00	0.00
Keratocytes, donor2	11607-120I5	3.52	1.17	0.00	0.00	0.00	0.00
Keratocytes, donor3	11688-122I5	15.61	8.50	3.36	0.40	0.00	0.00
Krukenberg tumor cell line:HSKTC	10687-109F3	118.69	94.51	0.00	4.40	2.20	0.00
Lens Epithelial Cells, donor1	11529-119I8	11.87	6.47	2.16	0.00	0.00	1.08
Lens Epithelial Cells, donor2	11609-120I7	22.72	10.38	7.38	2.88	0.46	0.00
Lens Epithelial Cells, donor3	11690-122I7	18.47	13.22	9.59	1.82	0.20	0.10
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	6.64	3.20	2.49	0.36	0.12	0.12
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	4.47	1.95	1.12	0.28	0.28	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	19.52	6.77	3.46	0.63	0.16	0.31
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	3.76	3.23	1.61	0.54	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	3.78	1.26	1.89	0.32	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	3.34	1.40	1.94	0.11	0.00	0.11
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	11.08	3.69	2.87	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	1.26	1.01	1.01	0.25	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	5.91	2.11	2.11	0.00	0.14	0.42
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	5.93	4.75	1.58	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	7.37	3.49	2.33	0.00	0.00	0.19
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	2.22	1.85	0.74	0.19	0.19	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	5.92	3.48	4.88	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	4.53	4.05	1.91	0.00	0.00	0.72
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	5.36	2.06	1.92	0.00	0.00	0.14
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	6.16	5.24	2.46	0.00	0.00	0.31
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	4.36	1.56	1.87	0.00	0.00	0.31
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	5.67	2.01	2.01	0.00	0.18	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	6.25	3.62	3.29	0.33	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	2.64	1.46	1.17	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	4.73	3.24	2.24	0.00	0.00	0.25
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	10.18	6.79	4.36	0.00	0.00	0.48
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	5.92	3.23	2.15	0.00	0.27	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	6.51	2.88	1.67	0.00	0.00	0.15
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	4.15	4.15	3.11	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	7.75	6.70	4.19	0.21	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	3.01	1.80	0.75	0.30	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	9.63	4.13	1.38	0.00	0.69	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	5.46	1.88	1.88	0.38	0.00	0.38
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	3.07	1.06	1.91	0.11	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	12.60	1.94	3.39	0.97	0.00	0.48
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	2.98	1.98	1.65	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	2.85	1.49	0.87	0.12	0.00	0.25
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	22.95	9.63	8.14	0.37	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	3.71	2.22	1.24	0.25	0.25	0.49
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	2.47	1.51	2.34	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	10.94	8.68	4.82	0.00	0.00	0.32
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	10.35	6.70	4.87	0.30	0.00	0.91
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	8.26	4.34	3.36	0.28	0.00	0.56
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	5.69	4.62	1.78	0.00	0.00	0.36
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	2.91	1.45	0.48	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	3.42	1.71	0.62	0.00	0.00	0.31
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	6.09	3.58	1.43	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	5.23	1.96	1.63	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	2.83	2.83	0.47	0.24	0.00	0.24
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	8.42	3.09	3.09	0.12	0.12	0.37
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	1.54	1.54	0.77	0.26	0.00	0.26
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	5.67	2.09	1.19	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	9.06	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	7.67	7.67	1.53	0.77	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	4.45	5.20	3.71	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	8.46	8.04	1.27	0.00	0.00	0.85
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	5.63	2.81	1.41	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	6.54	1.87	3.74	0.00	0.00	0.93
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	6.18	3.61	2.06	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	5.95	1.19	2.38	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	7.24	2.94	2.49	0.23	0.00	0.45
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	10.18	5.53	2.91	0.29	0.00	0.29
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	12.15	5.85	3.15	0.45	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	8.13	4.88	2.85	0.41	0.00	1.22
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	8.73	8.73	3.59	0.00	0.00	0.51
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	9.17	7.06	2.12	0.35	0.00	1.41
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	6.00	4.66	2.67	0.67	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	13.24	6.62	2.55	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	15.47	6.40	3.47	0.27	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	12.66	7.37	3.78	0.19	0.19	0.57
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	12.27	7.36	3.07	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	10.60	11.42	0.82	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	13.12	10.41	4.16	0.21	0.42	0.42
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	11.21	4.76	3.64	0.00	0.00	0.84
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	16.49	2.06	4.12	0.00	0.00	1.03
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	10.45	3.48	2.03	0.29	0.29	0.29
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	9.86	8.07	2.69	0.30	0.00	0.60
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	11.62	7.75	3.87	0.00	0.00	0.55
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	7.42	5.66	1.06	0.00	0.35	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	11.06	6.64	1.84	0.00	0.00	0.37
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	11.51	6.91	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	7.68	8.44	2.30	0.38	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	11.89	3.40	1.70	0.00	0.57	0.57
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	2.46	4.92	2.46	1.64	0.00	0.82
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	9.04	1.81	2.26	0.00	0.00	0.45
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	5.03	2.87	0.00	0.00	0.00	0.72
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	11.95	5.98	2.24	0.00	0.75	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	7.43	4.46	2.23	0.00	0.37	0.37
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	12.92	9.48	2.58	0.00	0.00	0.43
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	8.56	6.85	2.57	0.86	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	10.00	5.66	2.00	0.33	0.00	1.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	7.24	3.62	1.81	0.00	0.60	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	6.40	2.84	0.71	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	9.97	6.19	1.37	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	8.05	3.76	1.07	0.00	0.00	1.61
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	8.08	8.08	2.02	0.67	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	9.26	5.56	1.11	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	11.63	6.98	4.65	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	7.40	4.23	3.17	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	8.00	5.20	2.80	0.00	0.00	0.80
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	13.08	4.36	0.73	0.00	0.73	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	15.33	4.60	2.30	0.77	0.00	1.53
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	10.36	5.43	2.47	0.00	0.49	0.99
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	13.17	8.47	3.76	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	9.05	6.03	2.01	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	10.81	4.06	4.06	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	0.00	0.00	3.44	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	8.46	4.90	1.78	0.00	0.45	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	8.21	4.69	2.74	0.00	0.00	1.96
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	5.94	8.58	1.98	0.66	0.00	0.66
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	9.86	8.30	2.59	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	9.63	6.13	3.06	0.00	0.00	0.88
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	11.74	5.59	5.03	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	14.57	6.62	1.32	0.00	0.00	0.44
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	9.26	6.17	6.17	0.39	0.00	0.77
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	12.15	6.58	3.04	0.00	0.51	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	11.05	2.88	0.48	0.00	0.48	0.48
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	6.76	4.77	1.19	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	5.47	3.65	3.65	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	8.99	1.38	0.00	0.00	0.00	0.69
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	7.60	6.08	2.66	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	4.13	5.16	2.58	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	3.02	3.63	1.21	0.00	0.00	0.60
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	8.56	7.29	0.95	0.00	0.00	0.63
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	10.13	5.33	1.60	0.53	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	7.47	4.02	1.72	0.00	0.00	0.57
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	9.77	5.66	1.03	0.00	0.00	0.51
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	7.78	1.41	1.41	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	7.38	3.40	1.13	0.00	0.00	0.57
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	9.15	2.50	1.25	0.00	0.83	0.83
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	9.40	10.18	0.78	0.00	0.00	0.78
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	6.68	3.34	2.51	0.00	0.00	0.84
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	6.50	5.11	2.32	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	4.68	2.01	1.34	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	8.02	3.21	2.14	0.00	0.00	0.53
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	8.49	3.23	2.42	0.40	0.40	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	8.26	2.75	2.75	0.00	0.00	0.92
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	5.33	0.89	4.45	0.00	0.00	0.89
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	9.12	3.42	0.57	0.57	0.00	1.14
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	13.04	2.30	0.00	0.00	0.00	0.77
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	7.66	2.19	1.09	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	8.46	3.12	1.78	0.00	0.00	0.45
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	10.14	4.42	1.04	0.00	0.26	0.52
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	7.29	1.99	1.33	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	4.16	2.08	2.08	0.00	0.00	0.00
Macrophage - monocyte derived, donor1	11232-116C8	17.55	12.54	12.76	2.51	0.46	0.23
Macrophage - monocyte derived, donor2	11313-117C8	8.62	6.79	8.07	0.73	0.00	0.00
Macrophage - monocyte derived, donor3	11389-118C3	14.29	10.22	8.52	1.70	0.39	0.26
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	6.90	5.31	3.19	0.00	0.00	0.00
Mallassez-derived cells, donor2	11929-125I3	11.73	9.03	9.67	0.48	0.32	0.00
Mallassez-derived cells, donor3	11930-125I4	11.26	10.29	7.51	0.42	0.00	0.00
Mammary Epithelial Cell, donor1	11273-116H4	28.20	19.73	11.56	1.59	0.50	0.50
Mammary Epithelial Cell, donor2	11350-117G9	20.56	19.11	10.42	0.58	0.29	0.00
Mammary Epithelial Cell, donor3	11422-118F9	7.98	3.24	2.99	0.00	0.00	0.00
Mast cell - stimulated, donor1	11487-119E2	141.01	85.42	41.35	14.91	0.68	3.39
Mast cell, donor1	11563-120D6	31.69	19.68	6.81	2.49	0.65	0.32
Mast cell, donor2	11565-120D8	40.12	26.75	7.13	8.32	1.49	0.59
Mast cell, donor3	11566-120D9	43.00	36.92	6.08	9.00	2.93	0.45
Mast cell, donor4	11567-120E1	40.24	20.03	7.62	6.21	0.71	1.06
Mast cell, expanded and stimulated, donor5	11940-126A5	39.26	25.28	6.65	0.89	1.11	1.00
Mast cell, expanded and stimulated, donor8	11942-126A7	32.69	22.18	7.59	0.58	0.58	0.00
Mast cell, expanded, donor5	11939-126A4	31.32	14.23	5.51	1.95	0.69	0.34
Mast cell, expanded, donor8	11941-126A6	38.66	25.61	12.55	4.18	1.17	0.33
Melanocyte - dark, donor1	11502-119F8	12.54	7.36	10.15	1.39	0.00	0.10
Melanocyte - dark, donor2	11582-120F7	9.00	5.88	5.88	0.35	0.00	0.00
Melanocyte - dark, donor3	11663-122F7	25.28	15.65	5.65	3.69	0.07	0.36
Melanocyte - light, donor1	11274-116H5	4.47	1.41	1.18	0.00	0.00	0.00
Melanocyte - light, donor2	11351-117H1	4.78	2.05	0.68	0.00	0.00	0.00
Melanocyte - light, donor3	11423-118G1	9.54	0.87	0.87	0.00	0.00	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	18.95	10.10	4.69	2.08	0.31	0.10
Melanocyte, donor2 (MC+2)	12739-135I3	24.74	16.41	5.65	1.34	0.00	0.27
Melanocyte, donor3 (MC+3)	12837-137B2	20.89	14.46	9.37	1.87	0.00	0.54
Meningeal Cells, donor1	11493-119E8	10.55	3.72	3.47	0.25	0.12	0.12
Meningeal Cells, donor2	11573-120E7	8.80	1.76	3.96	0.44	0.00	0.00
Meningeal Cells, donor3	11654-122E7	25.27	16.79	6.76	1.63	0.00	0.24
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	13.40	6.56	4.28	0.86	0.00	0.86
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	14.39	11.47	8.55	0.20	0.30	0.30
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	2.63	2.63	1.31	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	2.62	0.00	1.31	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	14.35	5.02	5.74	1.44	0.00	0.00
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	8.68	5.51	3.60	0.42	0.00	0.00
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	5.53	6.53	5.03	0.00	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	5.05	2.42	2.20	0.00	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	4.38	2.19	2.19	0.00	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	5.52	3.48	2.05	0.61	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	11.08	7.06	5.68	1.66	0.14	0.00
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	3.72	4.46	1.12	0.00	0.00	0.00
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	17.10	11.18	9.21	1.58	0.00	0.26
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	4.75	2.37	0.59	0.00	0.00	0.30
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	0.00	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	3.84	0.64	0.00	0.00	0.00	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	15.24	7.80	4.96	0.35	0.00	0.35
Mesenchymal stem cells - hepatic, donor0	11218-116B3	14.07	6.88	4.07	2.50	0.00	0.00
Mesenchymal stem cells - umbilical, donor0	11214-116A8	12.34	7.26	2.18	0.73	0.00	0.73
Mesothelial Cells, donor1	11247-116E5	14.05	9.55	7.16	0.27	0.27	0.27
Mesothelial Cells, donor2	12156-128G5	8.51	4.00	2.50	0.00	0.00	0.00
Mesothelial Cells, donor3	11402-118D7	14.60	8.67	5.20	0.07	0.22	0.29
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	27.01	22.96	14.85	1.35	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	13.05	9.85	6.90	1.48	0.99	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	7.95	11.19	8.24	0.29	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	13.83	20.74	3.46	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	8.06	7.13	7.13	1.55	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	6.02	5.60	7.68	1.45	0.21	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	9.26	6.95	6.95	2.32	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	11.26	8.76	6.26	1.25	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	13.50	11.64	11.17	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	38.93	19.47	19.47	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	7.93	7.52	7.11	0.61	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	13.07	9.11	7.92	0.79	0.00	0.40
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	0.00	0.00	8.55	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	2.65	3.54	5.31	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	7.22	5.32	5.32	0.76	0.00	0.38
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	18.42	17.11	5.26	1.32	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	8.49	5.94	7.64	1.06	0.21	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	7.37	3.68	6.45	0.92	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	7.45	5.37	8.64	1.79	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	15.09	10.06	6.71	0.00	1.68	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	7.28	5.27	6.27	0.75	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	8.32	5.23	6.89	0.48	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	9.40	15.48	6.08	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	3.68	5.30	7.37	0.23	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	7.57	8.20	7.36	0.21	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	7.34	6.73	5.91	0.61	0.00	0.20
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	5.58	4.08	5.15	0.86	0.00	0.21
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	7.11	5.33	9.34	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	10.32	10.32	10.32	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	3.72	2.63	8.32	0.44	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	7.60	11.66	7.60	0.00	0.51	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	6.63	8.28	9.94	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	6.52	2.99	8.70	0.82	0.00	0.27
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	8.53	7.94	6.47	0.59	0.29	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	7.63	7.63	4.36	1.09	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	1.44	3.84	4.32	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	7.20	6.40	8.81	0.40	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	6.86	1.37	5.48	0.00	0.00	1.37
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	3.00	2.00	4.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	8.15	4.08	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	4.38	3.07	4.38	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	4.41	9.93	3.31	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	8.97	4.48	6.40	0.64	0.64	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	5.45	3.72	2.98	0.00	0.25	0.99
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	6.96	4.18	5.57	0.00	0.70	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	6.63	8.84	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	4.79	0.68	3.42	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	5.25	10.07	3.94	0.00	0.00	0.44
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	14.56	6.04	7.10	0.71	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	7.57	3.93	2.24	0.56	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	16.21	8.31	5.82	1.25	0.00	0.42
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	12.24	6.99	0.58	0.00	0.58	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	6.64	5.43	3.02	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	14.19	10.43	5.84	0.00	0.00	0.42
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	7.22	7.22	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	9.24	12.01	3.69	0.92	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	15.37	8.54	6.26	0.57	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	12.99	8.15	6.22	0.55	0.00	0.14
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	7.77	5.18	3.63	0.26	0.26	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	12.44	8.58	4.29	0.00	0.43	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	5.08	10.16	3.81	0.64	0.64	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	14.41	11.48	7.74	0.27	0.00	0.27
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	14.67	8.68	5.39	1.20	0.00	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	11.30	7.06	7.91	1.84	0.28	0.14
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	9.24	5.10	4.14	0.96	0.32	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	16.58	10.84	7.74	0.66	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	10.24	9.86	5.69	0.76	0.00	0.38
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	10.80	3.41	5.40	0.28	0.00	0.28
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	10.08	7.13	8.36	0.74	0.25	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	9.12	13.03	2.61	3.26	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	11.47	9.41	5.59	1.76	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	10.67	9.80	11.53	2.02	0.29	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	14.43	14.01	12.36	2.06	0.00	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	16.68	8.34	5.96	0.60	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	3.77	0.00	7.53	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	3.56	1.78	5.35	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	8.21	4.27	8.21	0.33	0.33	0.33
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	9.47	4.21	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	11.27	9.29	10.28	0.20	0.20	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	6.52	7.45	7.45	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	10.14	4.51	6.38	0.75	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	8.79	3.73	5.59	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	7.58	5.99	6.22	0.68	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	2.21	1.47	3.68	2.21	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	5.50	5.13	6.23	1.10	0.00	0.37
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	9.33	4.67	4.67	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	1.60	1.60	5.34	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	0.00	2.02	5.05	1.01	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	4.22	2.53	5.48	0.84	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	2.72	4.09	12.26	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	0.64	0.64	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	0.81	0.00	3.24	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	1.51	4.53	1.51	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	11.42	45.68	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	26.10	16.31	9.79	6.52	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	14.26	14.26	9.50	0.00	0.00	4.75
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	50.20	37.65	0.00	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	10.34	7.54	7.32	0.00	0.00	0.22
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	12.54	7.32	7.32	0.52	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	14.02	13.35	2.00	0.67	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	12.52	11.27	0.83	0.83	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	20.54	13.88	3.42	1.33	0.19	0.19
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	111.71	59.05	20.75	7.98	0.00	1.60
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	5.44	12.24	6.12	0.68	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	73.51	38.59	9.19	1.84	0.00	1.84
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	11.30	8.79	2.93	0.42	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	13.95	11.16	2.79	1.63	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	11.62	10.00	3.24	1.89	0.27	0.00
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	28.17	15.56	6.52	2.94	0.21	0.00
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	300.64	111.35	122.48	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	5.96	5.96	3.97	0.00	0.00	0.50
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	7.04	5.68	1.62	1.62	0.00	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	7.71	7.25	3.17	0.68	0.00	0.23
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	7.35	11.92	3.59	1.63	0.00	0.00
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	19.68	14.94	5.10	1.28	0.00	0.00
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	10.61	8.49	5.30	0.00	0.00	0.00
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	7.20	11.41	3.60	0.00	0.00	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	18.38	10.50	5.25	2.63	0.00	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	11.38	11.38	2.76	1.30	0.00	0.00
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	33.34	24.34	7.94	2.65	0.18	0.00
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	14.06	11.95	2.11	2.11	0.00	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	9.65	11.03	5.06	0.92	0.00	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	14.14	9.32	6.11	0.96	0.00	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	17.59	12.76	4.48	0.34	0.00	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	108.72	53.10	17.70	10.11	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	26.51	18.94	8.47	3.12	0.00	0.22
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	14.40	11.85	3.39	0.85	0.00	0.42
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	12.58	9.73	2.85	2.37	0.24	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	11.16	13.74	8.58	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	334.03	135.42	45.14	9.03	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	10.33	11.66	4.00	1.67	0.00	0.33
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	21.19	19.39	4.51	1.80	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	8.73	9.92	3.97	0.00	0.00	0.40
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	10.22	14.86	1.86	1.86	0.93	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	15.51	8.32	3.03	1.89	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	7.82	8.80	5.87	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	15.25	14.82	3.49	1.31	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	43.87	23.07	7.24	0.90	0.45	0.90
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	12.35	7.94	3.53	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	10.64	17.29	1.99	2.66	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	13.39	14.88	6.94	1.49	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	10.72	8.42	4.21	1.15	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	21.47	17.24	4.84	1.81	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	25.64	11.94	6.41	0.88	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	13.55	10.16	2.03	2.03	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	168.61	35.77	10.22	10.22	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	8.54	10.97	4.88	0.61	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	11.65	10.07	3.46	0.31	0.00	0.31
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	11.80	13.32	2.12	1.51	0.00	0.30
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	10.28	9.49	0.79	0.79	0.79	0.79
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	21.54	9.07	4.53	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	131.51	75.87	5.06	5.06	0.00	0.00
Myoblast, donor1	11241-116D8	13.91	9.81	5.22	0.62	0.12	0.12
Myoblast, donor2	11322-117D8	18.60	15.92	6.90	1.15	0.38	0.38
Myoblast, donor3	11398-118D3	24.22	17.15	8.41	2.35	0.50	0.17
NK T cell leukemia cell line:KHYG-1	10777-110G3	18.39	14.16	2.63	11.67	0.29	0.00
Natural Killer Cells, donor1	11230-116C6	34.44	32.90	9.53	5.84	5.23	0.92
Natural Killer Cells, donor2	11311-117C6	28.65	33.17	7.24	6.33	2.11	0.60
Natural Killer Cells, donor3	11387-118C1	30.00	24.66	6.99	5.52	4.42	0.55
Neural stem cells, donor1	11275-116H6	55.53	28.31	18.51	6.17	0.73	1.09
Neural stem cells, donor2	11352-117H2	53.92	32.74	26.96	13.48	0.00	0.00
Neurons, donor1	11494-119E9	14.79	10.24	7.97	4.55	0.00	1.14
Neurons, donor2	11574-120E8	15.19	8.59	6.38	3.52	0.22	0.22
Neurons, donor3	11655-122E8	13.98	13.15	12.33	2.47	0.82	0.00
Neutrophils, donor1	11233-116C9	73.31	71.46	12.99	0.93	2.78	10.21
Neutrophils, donor2	11314-117C9	52.18	52.18	17.39	2.90	5.80	11.60
Neutrophils, donor3	11390-118C4	150.27	156.38	29.32	1.22	6.72	11.61
Nucleus Pulposus Cell, donor1	11252-116F1	20.54	15.08	9.62	4.16	0.00	0.00
Nucleus Pulposus Cell, donor2	11409-118E5	6.19	3.91	3.58	0.98	0.00	0.00
Nucleus Pulposus Cell, donor3	11462-119B4	9.83	4.21	4.41	1.80	0.00	0.00
Olfactory epithelial cells, donor1	11933-125I7	13.77	8.40	6.06	1.10	0.14	0.28
Olfactory epithelial cells, donor2	11934-125I8	15.34	7.96	5.21	1.45	0.14	0.29
Olfactory epithelial cells, donor3	11935-125I9	14.07	8.97	6.70	0.57	0.11	0.00
Olfactory epithelial cells, donor4	11936-126A1	21.52	16.27	6.92	0.88	0.19	0.29
Oligodendrocyte - precursors, donor1	11496-119F2	16.25	11.43	2.41	0.00	0.00	0.00
Osteoblast - differentiated, donor1	11276-116H7	6.17	3.83	1.49	0.43	0.21	0.00
Osteoblast - differentiated, donor2	11353-117H3	3.43	3.43	1.14	0.00	0.00	0.00
Osteoblast - differentiated, donor3	11425-118G3	5.59	8.69	1.86	0.62	0.00	0.00
Osteoblast, donor1	11277-116H8	2.35	1.76	0.39	0.20	0.00	0.20
Osteoblast, donor2	11354-117H4	28.09	8.43	10.53	2.81	0.00	0.70
Osteoblast, donor3	11426-118G4	7.46	5.33	2.84	0.71	0.00	0.18
Pancreatic stromal cells, donor1	11249-116E7	17.94	12.80	8.17	0.51	0.00	0.59
Pericytes, donor1	11491-119E6	2.11	0.89	1.45	0.45	0.00	0.00
Pericytes, donor2	11571-120E5	1.81	1.13	1.13	0.23	0.00	0.00
Pericytes, donor3	11652-122E5	4.27	3.66	1.42	0.00	0.00	0.00
Perineurial Cells, donor1	11499-119F5	22.38	9.38	7.35	0.57	0.00	0.34
Perineurial Cells, donor2	11579-120F4	20.24	10.95	7.73	1.20	0.00	0.46
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	39.84	35.06	20.72	4.46	1.59	0.64
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	22.04	15.43	12.49	2.20	1.47	0.98
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	25.49	24.59	13.59	3.88	2.46	0.91
Placental Epithelial Cells, donor1	11278-116H9	6.94	6.22	0.48	0.48	0.00	0.00
Placental Epithelial Cells, donor2	11355-117H5	7.76	4.44	8.87	0.00	0.00	0.00
Placental Epithelial Cells, donor3	11427-118G5	5.69	4.52	2.55	0.59	0.00	0.00
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	0.00	2.22	0.95	0.00	0.00	0.63
Preadipocyte - breast, donor1	11467-119B9	9.94	8.44	6.38	0.38	0.00	0.19
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	49.60	34.46	12.40	2.09	0.39	0.65
Preadipocyte - breast, donor2	11328-117E5	8.11	8.56	6.53	0.68	0.23	0.00
Preadipocyte - omental, donor1	11468-119C1	12.47	9.16	6.93	0.64	0.11	0.21
Preadipocyte - omental, donor2	11329-117E6	13.97	10.91	3.06	0.00	0.00	0.00
Preadipocyte - omental, donor3	11403-118D8	10.31	6.88	3.44	0.00	0.00	0.29
Preadipocyte - perirenal, donor1	11469-119C2	1.97	2.95	1.97	0.00	0.00	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	4.91	6.45	2.15	0.00	0.00	0.61
Preadipocyte - subcutaneous, donor2	11356-117H6	27.09	19.83	7.08	1.42	0.00	0.53
Preadipocyte - subcutaneous, donor3	11428-118G6	11.24	7.83	5.62	0.68	0.00	0.17
Preadipocyte - visceral, donor1	11280-116I2	25.99	16.02	10.81	1.49	0.19	0.28
Preadipocyte - visceral, donor2	11357-117H7	20.25	19.79	9.66	0.00	0.00	0.46
Preadipocyte - visceral, donor3	11429-118G7	13.58	8.25	4.91	0.52	0.00	0.10
Prostate Epithelial Cells (polarized), donor1	11253-116F2	23.99	21.87	3.92	5.73	0.45	0.45
Prostate Epithelial Cells, donor2	11331-117E8	7.85	7.04	3.66	0.14	0.00	0.68
Prostate Epithelial Cells, donor3	11404-118D9	13.41	8.82	2.88	0.12	0.12	0.24
Prostate Stromal Cells, donor1	11254-116F3	15.60	8.66	3.08	0.46	0.11	0.11
Prostate Stromal Cells, donor2	11332-117E9	14.88	6.99	3.94	0.18	0.18	0.36
Prostate Stromal Cells, donor3	11405-118E1	11.05	5.11	3.55	0.31	0.10	0.10
Renal Cortical Epithelial Cells, donor1	11516-119H4	4.01	3.65	2.19	0.00	0.00	0.00
Renal Cortical Epithelial Cells, donor2	11596-120H3	14.97	11.51	5.27	1.11	0.14	0.35
Renal Epithelial Cells, donor1	11517-119H5	3.55	2.54	2.54	0.51	0.00	0.00
Renal Epithelial Cells, donor2	11597-120H4	5.69	2.13	0.00	0.00	0.00	0.00
Renal Epithelial Cells, donor3	11678-122H4	17.68	13.66	7.62	1.48	0.11	0.53
Renal Glomerular Endothelial Cells, donor1	11514-119H2	2.04	0.00	2.04	0.00	0.00	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	5.53	2.29	1.21	0.40	0.00	0.00
Renal Glomerular Endothelial Cells, donor3	11675-122H1	27.97	10.43	5.55	0.67	0.44	0.89
Renal Glomerular Endothelial Cells, donor4	11783-124B1	5.32	0.00	1.33	0.00	0.00	0.00
Renal Mesangial Cells, donor1	11518-119H6	3.52	2.42	0.66	0.44	0.00	0.00
Renal Mesangial Cells, donor2	11598-120H5	2.51	0.63	0.63	1.25	0.00	0.00
Renal Mesangial Cells, donor3	11679-122H5	2.22	0.83	0.28	0.55	0.00	0.28
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	9.13	2.15	2.42	0.54	0.27	0.27
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	2.11	1.69	0.84	0.00	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	4.05	2.51	1.54	0.00	0.19	0.19
Retinal Pigment Epithelial Cells, donor0	11215-116A9	15.82	9.85	6.74	1.30	0.00	0.00
Retinal Pigment Epithelial Cells, donor1	11528-119I7	6.25	1.99	3.13	0.57	0.00	0.00
Retinal Pigment Epithelial Cells, donor2	11608-120I6	4.12	0.00	0.00	1.03	0.00	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	15.81	5.52	6.77	0.75	0.00	0.25
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	30.60	24.19	9.22	2.41	0.67	0.94
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	50.92	31.27	3.57	4.47	0.00	0.89
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	60.54	34.67	5.50	5.50	0.55	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	133.41	107.89	16.24	13.34	0.00	0.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	54.74	26.66	12.61	4.03	0.39	0.39
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	29.00	21.35	8.04	2.48	0.00	0.10
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	41.05	30.12	11.93	4.57	0.00	0.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	39.32	19.60	8.93	3.10	0.25	0.25
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	32.63	21.56	7.93	2.21	0.12	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	56.40	32.36	10.63	3.47	0.23	0.46
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	33.95	18.76	6.43	2.05	0.14	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	39.48	19.51	8.47	3.48	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	44.44	32.61	8.42	3.58	0.36	0.36
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	23.53	14.49	6.17	1.43	0.14	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	27.90	16.74	5.79	1.18	0.00	0.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	41.16	22.13	8.41	2.21	0.66	0.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	32.12	19.12	9.56	1.72	0.00	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	35.59	19.19	6.34	2.33	0.00	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	59.19	38.15	16.91	6.58	0.19	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	33.71	20.04	7.70	2.52	0.27	0.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	40.10	24.92	10.03	3.50	0.19	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	37.81	23.30	10.88	2.67	0.38	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	31.61	17.83	6.09	2.78	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	37.00	18.22	7.85	3.08	0.00	0.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	50.24	29.22	11.28	2.91	0.17	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	26.62	20.06	8.75	2.92	0.18	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	32.50	20.48	10.91	1.59	0.00	0.37
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	35.59	27.54	7.92	3.09	0.27	0.67
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	25.47	13.92	8.26	2.83	0.24	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	25.60	20.04	9.92	3.37	0.00	0.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	35.54	27.36	8.42	3.27	0.00	0.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	19.70	13.69	6.22	2.28	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	29.64	15.93	9.95	2.65	0.44	0.44
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	40.31	28.83	9.82	4.39	0.00	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	29.61	16.15	9.96	2.02	0.00	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	45.47	28.27	9.71	4.43	0.17	0.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	43.19	29.88	13.50	6.75	0.19	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	27.17	15.82	7.39	2.06	0.00	0.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	37.72	24.83	10.70	5.35	0.00	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	48.76	29.88	13.13	4.27	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	28.46	18.41	6.48	2.39	0.00	0.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	28.56	14.20	8.73	2.66	0.30	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	45.85	28.79	11.46	3.20	0.00	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	30.56	16.87	4.56	3.18	0.00	0.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	27.86	18.10	5.71	1.67	0.00	0.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	69.13	37.08	14.11	6.45	0.60	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	27.69	14.22	5.46	1.51	0.00	0.09
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	45.77	30.39	11.18	3.49	0.00	0.35
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	48.35	31.73	8.76	4.23	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	24.48	9.91	3.06	1.35	0.00	0.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	99.41	67.25	17.47	10.48	0.58	0.44
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	43.81	25.55	6.69	4.87	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	25.02	13.56	3.92	1.81	0.00	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	26.69	19.00	5.20	0.68	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	49.12	35.65	5.69	7.49	0.60	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	21.96	11.57	3.54	1.53	0.12	0.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	24.33	17.29	2.99	2.13	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	67.31	44.47	7.81	3.61	0.00	0.00
Schwann Cells, donor1	11498-119F4	3.57	0.94	1.32	0.19	0.19	0.00
Schwann Cells, donor2	11578-120F3	23.82	10.21	0.00	0.00	0.00	0.00
Schwann Cells, donor3	11659-122F3	14.68	6.13	4.16	1.10	0.22	0.66
Sebocyte, donor1	11220-116B5	1.64	2.74	2.74	0.55	0.00	0.00
Sebocyte, donor2	11301-117B5	3.68	1.38	0.92	0.00	0.00	0.00
Sebocyte, donor3	11378-118B1	2.27	0.62	0.62	0.41	0.00	0.00
Sertoli Cells, donor1	11255-116F4	31.48	23.19	3.31	0.00	1.66	0.00
Sertoli Cells, donor2	11333-117F1	11.30	5.65	8.47	0.00	0.00	0.00
Skeletal Muscle Cells, donor1	11281-116I3	19.36	9.94	5.89	1.67	0.26	0.00
Skeletal Muscle Cells, donor2	11358-117H8	7.23	2.89	2.17	0.00	0.00	0.00
Skeletal Muscle Cells, donor3	11430-118G8	11.70	7.52	0.84	0.00	0.00	0.00
Skeletal Muscle Cells, donor4	11451-119A2	23.72	12.41	7.54	0.79	0.00	0.00
Skeletal Muscle Cells, donor5	11455-119A6	25.72	11.00	6.39	0.59	0.00	0.30
Skeletal Muscle Cells, donor6	11459-119B1	23.85	14.47	6.93	0.46	0.00	0.62
Skeletal Muscle Satellite Cells, donor1	11240-116D7	26.46	20.54	14.87	1.89	0.00	0.38
Skeletal Muscle Satellite Cells, donor2	11321-117D7	27.82	14.98	8.70	1.71	0.14	0.00
Skeletal Muscle Satellite Cells, donor3	11397-118D2	27.98	18.75	10.42	1.19	0.20	0.10
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	15.67	9.44	7.33	1.01	0.08	0.08
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	5.07	3.62	0.72	0.00	0.00	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	5.50	1.38	2.06	0.28	0.00	0.14
Skin - palm, donor1	10286-104F7	59.09	45.66	8.06	10.74	2.69	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	3.60	5.48	1.73	0.00	0.14	0.00
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	65.43	62.16	16.36	4.91	0.82	2.45
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	6.75	6.10	1.69	0.52	0.00	0.26
Small Airway Epithelial Cells, donor1	11256-116F5	11.68	12.51	5.56	0.42	0.00	0.14
Small Airway Epithelial Cells, donor2	11334-117F2	18.14	16.60	6.19	0.84	0.28	0.14
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	80.14	70.83	25.58	7.82	0.85	1.69
Small Airway Epithelial Cells, donor3	11406-118E2	14.99	18.29	4.50	0.37	0.22	0.22
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	4.01	2.47	0.93	0.00	0.00	0.00
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	24.23	13.12	8.67	0.89	0.44	0.67
Smooth Muscle Cells - Aortic, donor0	11210-116A4	19.99	12.93	4.11	1.18	0.59	0.59
Smooth Muscle Cells - Aortic, donor1	11283-116I5	5.52	3.31	1.33	0.66	0.00	0.44
Smooth Muscle Cells - Aortic, donor2	11360-117I1	3.15	3.15	1.18	0.00	0.00	0.79
Smooth Muscle Cells - Aortic, donor3	11432-118H1	23.18	12.36	3.09	0.77	0.77	1.55
Smooth Muscle Cells - Bladder, donor1	11519-119H7	21.02	6.00	7.01	2.00	0.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	5.19	4.13	2.79	0.13	0.00	0.13
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	15.96	8.87	6.87	0.44	0.22	0.00
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	7.17	4.23	1.66	0.26	0.00	1.15
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	21.81	9.77	9.77	0.65	0.00	0.33
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	22.15	15.36	11.52	2.07	0.00	0.00
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	11.82	11.96	5.84	0.43	0.00	0.14
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	0.49	0.33	0.33	0.00	0.00	0.00
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	16.13	8.52	5.18	0.91	0.00	0.00
Smooth Muscle Cells - Carotid, donor1	11285-116I7	6.06	4.04	2.27	0.25	0.00	0.00
Smooth Muscle Cells - Carotid, donor2	11362-117I3	6.12	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	6.20	4.29	2.38	0.00	0.00	0.48
Smooth Muscle Cells - Colonic, donor1	11239-116D6	14.89	11.95	5.90	0.59	0.29	0.00
Smooth Muscle Cells - Colonic, donor2	11320-117D6	13.99	10.76	6.24	0.86	0.00	0.00
Smooth Muscle Cells - Colonic, donor3	11396-118D1	17.32	10.08	5.25	0.73	0.21	0.00
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	4.64	3.71	2.47	0.00	0.00	0.00
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	2.16	4.31	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	9.86	4.48	1.79	0.00	0.00	0.00
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	3.07	2.05	2.73	0.00	0.00	0.00
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	21.67	15.00	8.64	2.04	0.08	0.00
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	15.80	10.57	6.54	0.10	0.40	0.00
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	16.84	8.42	4.32	0.68	0.00	0.91
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	11.47	4.83	1.21	0.00	0.60	0.00
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	25.70	16.43	7.68	0.26	0.00	0.53
Smooth Muscle Cells - Prostate, donor1	11257-116F6	17.84	7.19	5.06	1.07	0.13	0.27
Smooth Muscle Cells - Prostate, donor2	11335-117F3	17.03	7.89	5.01	0.75	0.13	0.38
Smooth Muscle Cells - Prostate, donor3	11465-119B7	6.60	6.34	3.04	1.78	0.00	0.25
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	11.46	8.29	4.37	0.60	0.00	0.15
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	6.75	5.25	2.25	0.75	0.00	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	1.29	0.00	0.00	1.29	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	12.09	9.77	4.19	1.40	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	15.65	11.11	3.03	0.50	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	7.21	2.51	2.19	0.00	0.00	0.31
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	0.59	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	34.16	18.16	9.33	2.67	0.17	0.33
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	15.42	7.47	5.14	1.40	0.00	0.00
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	4.75	2.73	1.30	0.00	0.00	0.14
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	9.94	5.10	2.04	0.51	0.25	0.00
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	1.69	3.20	1.32	0.38	0.00	0.00
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	21.10	12.72	7.55	2.10	0.14	0.56
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	11.65	8.30	3.77	0.59	0.00	0.17
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	2.38	1.43	0.95	0.00	0.00	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	4.16	3.18	0.49	0.00	0.24	0.24
Smooth Muscle Cells - Uterine, donor1	11258-116F7	11.27	8.18	4.64	0.88	0.00	0.00
Smooth Muscle Cells - Uterine, donor3	11466-119B8	12.00	8.19	3.51	0.59	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	10.50	11.08	3.50	0.39	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	10.05	8.99	3.70	0.26	0.26	0.53
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	12.27	8.18	2.60	0.37	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	12.22	7.91	7.55	0.36	0.36	0.36
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	9.37	8.52	4.26	0.85	0.28	0.28
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	16.15	10.24	3.15	1.18	0.00	0.39
Smooth muscle cells - airway, control, donor1	11966-126D4	16.00	12.44	6.35	1.27	0.51	0.25
Smooth muscle cells - airway, control, donor2	11967-126D5	17.57	16.77	3.99	0.40	0.40	0.40
Smooth muscle cells - airway, control, donor3	11968-126D6	10.45	7.11	2.51	1.67	0.00	0.00
Smooth muscle cells - airway, control, donor4	11969-126D7	11.00	12.83	3.21	0.00	0.00	0.00
Synoviocyte, donor1	11291-117A4	17.34	11.95	6.73	0.67	0.00	0.34
Synoviocyte, donor2	11368-117I9	11.06	9.72	3.86	0.17	0.00	0.34
Synoviocyte, donor3	11440-118H9	12.29	7.60	5.36	0.45	0.22	0.00
Trabecular Meshwork Cells, donor1	11532-120A2	5.00	4.29	2.50	0.36	0.00	0.00
Trabecular Meshwork Cells, donor2	11612-122A1	9.91	3.96	0.00	0.00	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	8.34	3.70	2.32	0.46	0.00	0.00
Tracheal Epithelial Cells, donor1	11292-117A5	7.10	5.95	3.37	0.29	0.00	0.00
Tracheal Epithelial Cells, donor2	11369-118A1	3.87	0.77	2.32	0.39	0.00	0.00
Tracheal Epithelial Cells, donor3	11441-118I1	4.01	1.72	1.72	0.00	0.00	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	33.34	24.36	10.83	2.34	0.49	0.12
Urethra, donor2	10319-105A4	44.96	28.77	16.19	1.80	0.00	3.60
Urothelial Cells, donor1	11520-119H8	0.27	0.53	1.59	0.00	0.00	0.00
Urothelial Cells, donor2	11600-120H7	2.40	1.20	1.20	0.00	0.00	0.00
Urothelial Cells, donor3	11681-122H7	2.98	1.15	1.38	0.00	0.00	0.00
Urothelial cells, donor0	11216-116B1	12.26	14.49	9.36	0.22	0.89	0.67
Whole blood (ribopure), donor090309, donation1	12179-129A1	30.25	24.02	6.23	3.56	0.00	3.56
Whole blood (ribopure), donor090309, donation2	12180-129A2	40.03	30.02	7.15	1.43	12.87	2.86
Whole blood (ribopure), donor090309, donation3	12181-129A3	34.23	18.48	8.21	0.00	0.00	1.37
Whole blood (ribopure), donor090325, donation1	12176-128I7	36.84	24.45	8.26	5.85	2.75	2.07
Whole blood (ribopure), donor090325, donation2	12177-128I8	36.02	18.59	8.13	5.81	2.91	1.74
Whole blood (ribopure), donor090612, donation1	12182-129A4	32.28	23.95	8.33	0.00	1.04	7.29
Whole blood (ribopure), donor090612, donation2	12183-129A5	38.55	31.20	10.10	1.84	2.75	2.75
Whole blood (ribopure), donor090612, donation3	12184-129A6	21.00	21.91	6.39	1.83	1.83	2.74
Wilms' tumor cell line:G-401	10809-111A8	44.90	14.06	8.64	0.62	0.00	0.25
Wilms' tumor cell line:HFWT	10597-108E3	73.04	36.96	4.40	3.52	0.00	2.64
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	46.93	28.49	14.80	1.68	0.28	0.84
achilles tendon, donor2	10292-104G4	20.67	18.60	8.27	2.07	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	55.07	23.46	6.37	4.59	1.53	0.76
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	59.67	27.16	9.98	11.14	0.00	0.93
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	90.10	44.04	13.18	1.66	0.83	1.19
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	55.51	20.68	7.35	0.27	0.54	0.82
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	80.11	33.45	24.45	3.09	0.00	0.28
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	46.31	21.78	9.09	0.63	0.21	0.42
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	36.48	29.13	9.26	3.27	0.27	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	41.42	33.93	7.05	4.85	0.00	0.88
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	32.67	26.14	11.43	4.08	0.41	0.00
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	35.72	21.36	8.54	8.54	0.39	0.00
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	47.47	22.08	6.44	1.47	0.37	0.00
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	78.01	15.60	15.60	3.90	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	32.07	15.57	7.90	2.09	0.23	0.46
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	56.18	33.92	10.10	2.33	0.00	0.00
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	54.36	23.67	13.74	0.58	0.29	0.88
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	46.48	19.52	6.04	6.04	1.86	0.46
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	39.48	30.84	4.94	0.41	0.00	0.41
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	110.81	75.51	15.35	0.61	0.00	0.61
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	72.97	48.64	18.78	1.28	0.43	0.85
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	100.09	52.17	20.32	1.82	0.61	0.61
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	89.06	50.79	23.59	2.65	0.48	0.96
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	59.69	26.51	13.36	1.11	0.67	0.67
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	59.70	27.68	14.68	1.00	1.00	0.33
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	159.81	85.48	26.01	3.72	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	50.85	20.34	22.60	0.38	0.38	1.13
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	85.05	41.00	30.53	4.80	0.00	0.00
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	73.10	59.98	29.99	26.24	0.00	0.00
adenocarcinoma cell line:IM95m	10796-110I4	23.31	23.55	5.18	0.94	0.00	0.00
adipose tissue, adult, pool1	10010-101C1	25.44	16.13	11.01	1.40	0.93	0.78
adipose, donor1	10184-103D4	73.30	22.87	17.01	15.83	0.00	0.00
adipose, donor2	10185-103D5	33.66	11.76	3.65	2.03	0.81	0.00
adipose, donor3	10186-103D6	37.03	9.53	5.45	2.72	0.27	0.27
adipose, donor4	10187-103D7	31.20	8.67	4.33	2.60	0.00	0.87
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	57.60	25.41	16.73	2.21	0.47	0.63
adrenal gland, adult, pool1	10081-102A9	10.91	3.64	3.64	0.00	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	37.35	18.54	8.14	2.00	0.13	0.53
alveolar cell carcinoma cell line:SW 1573	10708-109H6	50.74	28.58	5.00	0.36	0.00	0.00
amniotic membrane cells, donor1	12235-129G3	19.01	16.93	9.97	0.93	0.93	0.93
amniotic membrane cells, donor2	12236-129G4	16.23	10.48	7.10	1.69	0.00	0.00
amniotic membrane cells, donor3	12237-129G5	16.20	12.67	8.54	2.65	0.88	0.88
amygdala - adult, donor10196	10167-103B5	13.04	11.86	11.86	2.37	0.00	0.00
amygdala, adult, donor10252	10151-102I7	27.37	15.61	7.71	4.06	2.43	0.81
amygdala, newborn, donor10223	10360-105E9	16.46	8.71	5.16	1.29	0.00	0.00
anaplastic carcinoma cell line:8305C	10428-106D5	17.95	12.99	4.33	2.42	0.25	0.00
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	56.04	35.96	9.27	0.22	0.44	0.44
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	102.22	81.51	10.36	4.34	0.00	2.67
aorta, adult, pool1	10052-101G7	12.94	6.86	4.12	1.37	0.78	0.98
appendix, adult	10189-103D9	47.74	30.27	13.58	8.93	2.72	1.94
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	33.36	18.23	25.11	8.94	0.69	0.69
artery, adult	10190-103E1	23.10	14.95	4.08	2.72	1.36	1.36
astrocytoma cell line:TM-31	10425-106D2	55.19	24.92	18.25	6.81	0.00	0.29
b cell line:RPMI1788	10427-106D4	41.79	21.71	5.65	1.19	1.78	1.64
basal cell carcinoma cell line:TE 354.T	10702-109G9	16.92	9.99	5.83	0.83	0.28	0.28
bile duct carcinoma cell line:HuCCT1	10432-106D9	58.35	32.94	17.86	0.79	0.20	0.40
bile duct carcinoma cell line:TFK-1	10496-107C1	35.15	29.12	5.36	0.00	0.33	0.50
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	34.67	23.49	3.91	0.00	0.00	0.00
bladder, adult, pool1	10011-101C2	34.44	20.53	9.34	2.39	1.85	2.17
blood, adult, pool1	10053-101G8	11.07	8.86	2.21	2.21	0.00	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	35.97	41.96	10.28	4.28	0.00	0.86
bone marrow, adult	10192-103E3	37.79	18.90	14.17	2.02	1.35	2.02
brain, adult, donor1	10084-102B3	9.23	3.08	3.08	2.05	0.00	0.00
brain, adult, pool1	10012-101C3	19.04	10.36	7.91	1.89	1.22	0.78
brain, fetal, pool1	10085-102B4	8.01	2.67	5.34	0.00	0.00	0.00
breast carcinoma cell line:MCF7	10482-107A5	73.67	44.60	14.21	1.98	1.65	1.32
breast carcinoma cell line:MDA-MB-453	10419-106C5	52.30	52.92	11.73	13.11	0.62	0.87
breast, adult, donor1	10080-102A8	20.83	9.47	6.31	1.26	1.89	2.53
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	31.38	15.75	12.45	1.40	0.51	0.89
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	30.61	19.79	4.64	3.09	0.00	0.31
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	32.69	11.51	5.06	0.92	0.46	0.92
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	27.60	20.58	5.08	0.48	0.48	0.48
carcinoid cell line:NCI-H1770	10703-109H1	53.60	25.86	15.99	7.05	0.47	0.00
carcinoid cell line:NCI-H727	10735-110B6	49.00	23.63	4.05	2.52	0.55	0.77
carcinoid cell line:SK-PN-DW	10719-109I8	36.44	23.45	10.46	1.90	0.00	0.00
carcinosarcoma cell line:JHUCS-1	10642-109A3	112.33	40.73	23.16	8.25	0.00	0.27
caudate nucleus - adult, donor10196	10177-103C6	39.14	14.97	13.82	1.15	1.15	0.00
caudate nucleus, adult, donor10252	10164-103B2	25.27	13.89	15.73	3.68	0.67	0.84
caudate nucleus, adult, donor10258	10379-105H1	19.10	15.28	23.69	2.29	2.29	0.00
caudate nucleus, newborn, donor10223	10354-105E3	24.54	9.89	9.16	1.83	0.00	1.46
cerebellum - adult, donor10196	10173-103C2	96.14	43.70	11.65	5.83	0.00	2.91
cerebellum, adult, donor10252	10166-103B4	76.44	35.44	9.61	4.06	4.06	1.92
cerebellum, adult, pool1	10083-102B2	24.15	14.49	3.45	0.69	0.34	0.00
cerebellum, newborn, donor10223	10357-105E6	87.18	48.99	8.30	3.32	1.66	2.49
cerebral meninges, adult	10188-103D8	29.50	15.63	11.60	5.29	1.01	0.76
cerebrospinal fluid, donor2	10294-104G6	10.96	13.89	4.39	0.73	0.00	0.73
cervical cancer cell line:D98-AH2	10552-107I3	59.81	43.28	7.76	0.43	0.72	0.43
cervical cancer cell line:ME-180	10553-107I4	26.35	20.55	5.63	1.99	0.00	0.00
cervix, adult, pool1	10013-101C4	38.32	25.62	10.18	3.25	1.99	1.47
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	30.38	18.11	4.74	1.11	0.28	0.56
chondrosarcoma cell line:SW 1353	10700-109G7	28.74	27.43	3.92	0.00	1.31	0.00
choriocarcinoma cell line:BeWo	10423-106C9	66.24	41.26	13.55	5.34	0.25	0.87
choriocarcinoma cell line:SCH	10785-110H2	43.12	17.13	11.83	0.49	0.62	0.49
choriocarcinoma cell line:T3M-3	10618-108G6	59.06	25.85	11.38	0.24	0.95	0.47
chorionic membrane cells, donor1	12238-129G6	12.25	12.25	3.42	1.14	1.14	1.42
chorionic membrane cells, donor2	12239-129G7	17.50	9.45	5.27	0.89	0.20	0.10
chorionic membrane cells, donor3	12240-129G8	21.98	15.94	6.04	0.00	0.00	0.55
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	7.07	10.10	0.00	0.00	0.00	0.00
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	47.45	27.66	7.88	3.27	0.58	0.19
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	60.19	36.54	17.74	14.36	0.21	0.84
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	86.03	63.69	16.95	1.80	0.00	0.51
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	104.73	69.66	15.96	2.66	0.00	0.97
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	101.80	60.68	18.12	1.63	0.41	1.63
chronic myelogenous leukemia cell line:K562	10454-106G4	89.51	64.78	24.73	3.24	0.29	0.59
chronic myelogenous leukemia cell line:KU812	10409-106B4	94.09	49.00	47.17	19.81	0.00	0.52
clear cell carcinoma cell line:JHOC-5	10638-108I8	45.49	26.06	10.06	2.06	0.23	0.23
clear cell carcinoma cell line:TEN	10636-108I6	19.95	18.91	6.07	0.52	0.17	0.17
colon carcinoma cell line:CACO-2	10513-107D9	48.14	34.59	10.80	4.76	0.00	1.46
colon carcinoma cell line:COLO-320	10420-106C6	34.59	18.24	9.12	14.06	0.00	0.38
colon, adult, donor1	10082-102B1	10.71	3.57	4.76	2.38	0.00	0.00
colon, adult, pool1	10014-101C5	34.66	31.02	12.22	3.64	0.82	0.82
colon, fetal, donor1	10070-101I7	32.14	21.63	8.65	5.56	0.62	0.00
common myeloid progenitor CMP, donor1	12130-128D6	362.10	197.09	27.50	32.08	4.58	0.00
common myeloid progenitor CMP, donor2	12134-128E1	50.07	25.04	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	98.58	76.91	20.40	3.82	1.27	0.00
cord blood derived cell line:COBL-a 24h infection	10453-106G3	50.41	33.96	8.45	0.45	0.00	0.30
cord blood derived cell line:COBL-a untreated	10449-106F8	60.92	36.10	9.59	0.56	0.14	1.27
corpus callosum, adult, pool1	10042-101F6	15.15	7.74	5.97	2.10	1.33	0.44
cruciate ligament, donor2	10295-104G7	25.12	20.26	6.48	4.86	0.00	0.81
diaphragm, fetal, donor1	10069-101I6	25.68	13.64	7.22	1.61	0.00	0.80
diencephalon, adult	10193-103E4	24.96	9.36	13.44	1.68	1.68	0.72
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	50.28	30.77	7.12	6.66	1.15	0.23
ductal cell carcinoma cell line:KLM-1	10438-106E6	67.19	44.88	20.00	5.90	0.00	0.26
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	35.87	26.72	9.15	1.44	0.24	0.24
ductus deferens, adult	10196-103E7	42.36	30.40	10.96	1.99	1.50	0.50
duodenum, fetal, donor1, tech_rep1	10071-101I8	31.69	17.28	7.20	4.32	1.44	1.44
duodenum, fetal, donor1, tech_rep2	10071-101I8	41.20	24.28	25.01	6.62	0.74	1.47
dura mater, adult, donor1	10041-101F5	28.58	14.21	9.50	1.40	0.83	0.25
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	61.29	37.53	8.44	6.88	0.22	2.22
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	32.81	17.34	17.20	4.16	0.14	0.57
embryonic pancreas cell line:1B2C6	10604-108F1	66.59	33.30	8.63	0.00	0.00	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	28.15	19.98	3.94	0.30	0.30	0.30
embryonic pancreas cell line:1C3IKEI	10606-108F3	53.41	28.71	6.48	0.00	0.00	0.00
embryonic pancreas cell line:2C6	10603-108E9	89.32	49.91	2.63	0.00	0.00	1.31
endometrial carcinoma cell line:OMC-2	10497-107C2	113.30	55.98	19.11	2.01	1.01	1.01
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	45.67	23.56	6.34	3.62	0.18	0.18
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	13.83	8.52	9.97	0.48	0.00	0.32
epidermoid carcinoma cell line:A431	10426-106D3	50.58	34.01	15.12	3.67	0.11	0.78
epidermoid carcinoma cell line:Ca Ski	10431-106D8	49.16	31.79	6.82	1.76	0.66	0.88
epididymis, adult	10197-103E8	39.14	20.30	9.63	5.44	0.42	0.42
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	40.63	17.21	12.95	1.24	0.00	0.35
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	33.43	15.34	8.65	0.39	0.00	0.39
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	68.15	41.02	12.97	1.57	0.13	0.92
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	81.49	46.26	17.32	0.98	0.30	0.39
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	71.92	42.12	14.00	0.78	0.34	0.90
esophagus, adult, pool1	10015-101C6	25.27	15.40	8.39	1.70	0.42	0.32
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	128.24	54.60	21.67	0.38	1.63	1.13
eye - muscle inferior rectus, donor1	10272-104E2	57.95	43.46	4.83	0.00	0.00	0.00
eye - muscle lateral, donor2	10298-104H1	25.25	29.46	8.42	4.21	0.00	0.00
eye - muscle medial, donor2	10299-104H2	62.51	22.32	2.98	2.98	0.00	0.00
eye - muscle superior, donor2	10297-104G9	41.27	28.66	1.15	4.59	1.15	1.15
eye - vitreous humor, donor1	10268-104D7	16.03	10.20	4.37	1.46	0.00	0.00
eye, fetal, donor1	10054-101G9	35.59	14.75	6.86	2.29	0.25	0.76
fibrosarcoma cell line:HT-1080	10758-110E2	24.75	14.75	7.44	0.13	0.13	0.13
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	31.34	17.57	5.22	0.71	0.24	0.24
frontal lobe, adult, pool1	10040-101F4	22.99	9.85	12.48	2.16	1.31	0.84
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	67.86	27.62	14.11	6.31	0.60	0.60
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	48.64	38.40	12.25	1.10	0.55	1.01
gall bladder, adult	10198-103E9	21.97	17.87	9.42	1.21	0.24	0.72
gamma delta positive T cells, donor1	11937-126A2	27.38	27.92	12.88	7.52	2.68	2.15
gamma delta positive T cells, donor2	11938-126A3	28.39	21.66	5.98	5.60	2.61	0.00
gastric adenocarcinoma cell line:MKN1	10614-108G2	30.63	19.43	7.82	1.69	0.00	0.63
gastric adenocarcinoma cell line:MKN45	10612-108F9	39.84	26.69	7.16	1.16	0.19	0.39
gastric cancer cell line:AZ521	10549-107H9	63.61	31.15	34.43	1.80	0.00	0.98
gastric cancer cell line:GSS	10560-108A2	37.52	19.22	7.32	6.41	0.00	0.00
gastrointestinal carcinoma cell line:ECC12	10615-108G3	37.01	22.16	5.94	8.00	0.23	0.69
giant cell carcinoma cell line:LU65	10487-107B1	11.24	13.31	1.95	0.00	0.00	0.00
giant cell carcinoma cell line:Lu99B	10433-106E1	66.76	30.09	12.32	0.84	0.84	0.98
glassy cell carcinoma cell line:HOKUG	10688-109F4	37.66	24.69	4.99	2.74	0.25	0.25
glioblastoma cell line:A172, tech_rep1	10444-106F3	64.60	41.38	14.99	1.37	0.84	0.53
glioblastoma cell line:A172, tech_rep2	10444-106F3	67.97	44.10	14.75	1.97	0.70	0.84
glioblastoma cell line:T98G	10485-107A8	36.42	21.52	3.86	3.31	0.22	0.66
glioma cell line:GI-1	10413-106B8	58.58	31.92	13.18	1.17	0.00	0.29
globus pallidus - adult, donor10196	10175-103C4	26.97	13.12	6.56	2.19	0.00	2.19
globus pallidus, adult, donor10252	10161-103A8	42.23	16.60	14.40	6.10	2.69	2.20
globus pallidus, adult, donor10258	10367-105F7	6.85	6.85	5.48	6.85	0.00	1.37
globus pallidus, newborn, donor10223	10364-105F4	19.19	10.13	8.53	0.53	0.00	0.53
granulocyte macrophage progenitor, donor1	12131-128D7	381.75	266.74	29.37	17.13	0.00	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	43.71	32.79	10.93	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	0.00	10.45	0.00	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	22.72	17.28	9.28	2.24	0.32	0.00
hIPS +CCl2, biol_rep1	14383-156B9	21.12	9.18	8.72	6.89	0.00	0.46
hIPS +CCl2, biol_rep2	14384-156C1	23.78	11.43	12.35	6.86	0.00	0.00
hIPS +CCl2, biol_rep3	14385-156C2	23.19	10.95	4.51	4.51	0.00	0.00
hIPS, biol_rep1	14380-156B6	20.12	15.81	8.62	5.75	0.00	1.44
hIPS, biol_rep2	14381-156B7	12.35	13.03	6.86	2.74	0.00	0.00
hIPS, biol_rep3	14382-156B8	22.07	13.24	7.72	1.10	0.00	1.10
hairy cell leukemia cell line:Mo	10712-109I1	25.00	14.65	6.03	1.44	0.29	0.29
heart - mitral valve, adult	10205-103F7	42.15	19.13	11.36	4.48	0.90	1.20
heart - pulmonic valve, adult	10206-103F8	52.56	25.62	16.73	5.75	0.78	1.57
heart - tricuspid valve, adult	10207-103F9	38.30	30.81	10.82	5.00	0.00	0.83
heart, adult, diseased post-infarction, donor1	10050-101G5	20.20	11.84	7.35	0.61	0.41	0.41
heart, adult, diseased, donor1	10051-101G6	8.94	6.81	2.55	1.70	0.43	0.00
heart, adult, pool1	10016-101C7	39.79	26.22	10.58	5.06	0.69	0.46
heart, fetal, pool1	10046-101G1	30.50	18.28	10.17	7.80	0.31	0.62
hepatic mesenchymal tumor cell line:LI90	10778-110G4	21.29	17.89	8.64	0.62	0.62	0.31
hepatoblastoma cell line:HuH-6	10633-108I3	121.30	72.54	11.89	1.19	0.00	1.19
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	67.07	28.07	10.50	5.08	0.00	0.44
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	62.14	28.28	13.11	5.10	0.24	0.49
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	71.65	32.03	14.35	4.45	0.20	0.30
hepatoma cell line:Li-7	10484-107A7	33.14	22.91	9.34	1.56	0.22	0.44
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	33.27	16.68	3.82	1.31	0.40	0.40
hippocampus - adult, donor10196	10169-103B7	19.87	15.14	3.79	2.84	0.00	2.84
hippocampus, adult, donor10252	10153-102I9	30.21	15.10	12.25	3.67	1.02	1.63
hippocampus, adult, donor10258	10374-105G5	14.44	14.44	10.46	2.99	0.00	1.00
hippocampus, newborn, donor10223	10363-105F3	15.86	4.93	7.05	1.06	0.35	0.70
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	51.27	17.09	9.16	4.88	0.61	1.22
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	34.95	12.37	10.01	2.16	0.59	0.79
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	37.07	16.25	12.44	1.52	0.51	0.51
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	21.43	7.33	9.02	3.38	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	29.18	9.55	13.94	6.97	0.00	0.52
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	25.81	9.49	16.70	8.35	1.14	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	51.97	19.56	8.76	5.26	0.29	0.58
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	57.30	10.13	6.89	5.17	0.65	0.65
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	56.72	20.44	7.09	3.75	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	50.67	16.58	9.23	3.08	0.71	0.24
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	52.55	16.88	7.23	3.38	0.00	0.64
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	51.84	21.55	12.12	2.02	0.00	0.67
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	30.36	12.36	9.08	2.03	0.31	0.47
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	33.90	9.33	4.42	1.97	0.00	0.49
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	28.80	17.46	10.47	6.11	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	34.36	9.93	13.55	8.40	0.19	0.38
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	41.43	8.29	10.47	4.80	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	35.98	10.49	13.99	4.50	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	43.52	6.22	4.14	3.39	1.13	0.19
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	50.02	10.46	3.64	5.00	0.45	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	38.53	10.02	3.76	2.51	0.63	0.63
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	37.72	10.45	3.43	0.33	0.00	0.16
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	40.93	10.45	3.19	0.87	0.58	0.29
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	34.08	14.95	3.59	2.69	0.60	0.90
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	36.39	10.35	7.76	1.85	0.18	0.18
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	28.53	9.41	7.99	2.85	0.00	0.57
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	35.93	16.33	10.62	3.67	0.41	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	38.02	9.86	10.56	3.87	0.35	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	28.82	11.09	8.24	3.80	0.00	0.32
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	30.56	9.99	9.99	2.72	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	44.47	11.89	5.69	3.10	0.52	0.52
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	45.83	11.29	5.98	1.99	0.00	1.33
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	48.74	14.11	7.95	2.57	0.51	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	40.14	14.06	8.69	2.56	0.26	0.26
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	54.52	16.66	6.06	0.76	0.76	0.76
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	39.99	11.43	7.39	1.34	0.34	1.01
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	35.74	10.14	7.97	2.90	0.00	0.72
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	32.09	13.82	8.47	1.78	0.45	0.45
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	27.32	11.71	10.24	2.44	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	33.92	10.09	9.17	6.72	0.31	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	224.47	55.31	39.04	45.55	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	34.09	11.91	10.92	4.96	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	64.03	11.49	7.11	6.57	0.55	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	43.43	15.92	3.98	2.17	0.00	0.72
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	43.77	9.25	3.91	3.56	0.36	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	47.74	9.55	4.77	4.77	1.19	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	67.31	18.28	9.34	4.20	0.41	1.76
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	26.67	9.70	5.66	1.62	0.27	0.54
immature langerhans cells, donor1	11904-125F5	27.36	28.09	12.35	4.36	0.00	0.73
immature langerhans cells, donor2	11905-125F6	14.26	22.97	11.88	2.38	0.00	0.00
insula, adult, pool1	10039-101F3	10.50	6.06	8.23	1.32	0.47	0.28
keratoacanthoma cell line:HKA-1	10791-110H8	17.56	13.33	6.50	0.98	0.00	0.00
kidney, adult, pool1	10017-101C8	28.04	14.22	11.11	3.40	0.70	0.90
kidney, fetal, pool1	10045-101F9	16.91	9.05	6.15	1.13	0.35	0.28
large cell lung carcinoma cell line:IA-LM	10509-107D5	64.05	36.64	29.54	2.70	0.14	0.43
large cell lung carcinoma cell line:NCI-H460	10839-111E2	18.39	6.36	5.25	0.55	0.14	0.00
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	33.58	24.41	4.95	0.73	0.18	0.92
left atrium, adult, donor1	10079-102A7	20.16	13.08	5.45	4.36	1.09	0.00
left ventricle, adult, donor1	10078-102A6	13.65	8.09	1.52	3.54	1.01	1.01
leiomyoblastoma cell line:G-402	10721-110A1	51.44	30.92	9.03	1.37	0.00	0.55
leiomyoma cell line:10964C	10569-108B2	2.87	0.36	1.80	0.00	0.00	0.00
leiomyoma cell line:15242A	10570-108B3	1.63	0.54	1.09	0.00	0.00	0.54
leiomyoma cell line:15425	10571-108B4	5.34	6.31	2.91	0.24	0.00	0.24
leiomyosarcoma cell line:Hs 5.T	10722-110A2	19.05	12.70	0.00	6.35	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	38.69	36.59	6.27	0.00	1.05	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	38.49	30.81	9.56	2.01	0.35	0.12
liposarcoma cell line:KMLS-1	10782-110G8	24.68	10.47	7.81	0.94	0.00	0.00
liposarcoma cell line:SW 872	10726-110A6	26.32	15.72	6.94	2.92	0.00	0.12
liver, adult, pool1	10018-101C9	21.39	16.04	9.40	1.30	0.16	0.32
liver, fetal, pool1	10086-102B5	3.76	5.64	0.94	0.00	0.94	0.00
locus coeruleus - adult, donor10196	10182-103D2	22.89	10.06	8.17	2.19	2.77	0.87
locus coeruleus, adult, donor10252	10165-103B3	25.65	10.15	8.49	3.14	1.29	1.11
locus coeruleus, adult, donor10258	10375-105G6	17.21	9.03	6.77	1.69	0.85	0.85
locus coeruleus, newborn, donor10223	10362-105F2	30.71	15.98	10.94	3.79	1.68	1.68
lung adenocarcinoma cell line:A549	10499-107C4	31.00	18.27	10.24	0.28	0.14	0.00
lung adenocarcinoma cell line:PC-14	10408-106B3	69.63	55.15	11.72	6.20	1.38	1.38
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	58.53	38.36	7.78	2.77	0.26	0.26
lung, adult, pool1	10019-101D1	28.35	22.92	7.56	2.24	1.65	1.54
lung, fetal, donor1	10068-101I5	72.78	34.25	23.97	3.71	1.71	2.57
lung, right lower lobe, adult, donor1	10075-102A3	17.87	14.66	9.62	1.37	0.00	1.37
lymph node, adult, donor1	10077-102A5	19.88	13.25	7.57	2.84	1.42	0.00
lymphangiectasia cell line:DS-1	10727-110A7	43.18	26.30	12.27	1.32	0.22	0.00
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	28.68	20.98	3.47	10.56	0.45	0.45
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	50.12	36.53	3.40	0.00	0.00	0.00
mature adipocyte, donor1	12231-129F8	43.95	34.63	17.32	2.66	0.00	1.78
mature adipocyte, donor2	12232-129F9	47.11	38.81	15.36	2.28	0.62	2.08
mature adipocyte, donor3	12233-129G1	29.16	22.52	11.62	1.19	1.19	0.24
mature adipocyte, donor4	12234-129G2	44.48	30.27	10.53	3.16	1.05	0.79
maxillary sinus tumor cell line:HSQ-89	10414-106B9	59.56	61.71	24.06	8.10	0.24	0.48
medial frontal gyrus - adult, donor10196	10170-103B8	33.84	18.05	14.66	1.13	0.00	0.00
medial frontal gyrus, adult, donor10252	10150-102I6	33.65	16.00	12.51	2.76	1.47	0.55
medial frontal gyrus, adult, donor10258	10368-105F8	17.16	9.53	5.72	2.22	1.27	0.00
medial frontal gyrus, newborn, donor10223	10352-105E1	34.97	12.79	9.38	2.99	0.43	0.43
medial temporal gyrus - adult, donor10196	10183-103D3	28.69	9.79	14.18	1.35	2.53	1.35
medial temporal gyrus, adult, donor10252	10156-103A3	29.07	14.01	13.58	3.40	1.91	1.06
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	13.48	17.34	11.56	3.85	0.00	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	287.07	86.12	57.41	14.35	28.71	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	17.95	9.33	9.69	1.08	0.00	1.44
medulla oblongata - adult, donor10196	10174-103C3	31.15	17.52	5.19	3.89	1.95	1.30
medulla oblongata, adult, donor10252	10155-103A2	37.00	15.48	11.15	2.32	2.17	1.55
medulla oblongata, adult, pool1	10038-101F2	11.10	3.84	3.92	1.88	0.82	0.24
medulla oblongata, newborn, donor10223	10361-105F1	26.39	15.97	7.99	1.74	0.35	1.04
medulloblastoma cell line:D283 Med	10838-111E1	157.20	40.30	20.59	3.54	1.33	1.33
medulloblastoma cell line:ONS-76	10759-110E3	43.53	31.79	8.68	2.81	0.49	0.61
melanoma cell line:COLO 679	10514-107E1	45.42	23.14	5.32	2.59	0.29	0.57
melanoma cell line:G-361	10465-106H6	24.70	17.37	1.63	0.54	0.00	0.27
meningioma cell line:HKBMM	10691-109F7	12.12	8.32	6.15	0.36	0.18	0.36
merkel cell carcinoma cell line:MKL-1	10843-111E6	63.44	40.53	17.62	21.15	0.00	0.00
merkel cell carcinoma cell line:MS-1	10844-111E7	61.18	27.48	22.03	7.26	0.00	0.52
mesenchymal precursor cell - adipose, donor1	11747-123G1	15.50	7.83	7.52	1.23	0.00	0.15
mesenchymal precursor cell - adipose, donor2	11748-123G2	11.27	7.09	4.36	1.64	0.00	0.18
mesenchymal precursor cell - adipose, donor3	11749-123G3	8.70	4.14	7.04	0.00	0.00	0.41
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	11.24	6.74	3.65	0.00	0.00	0.00
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	8.28	4.81	3.47	0.58	0.00	0.00
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	21.52	13.88	9.02	0.69	0.00	0.00
mesenchymal precursor cell - cardiac, donor1	11752-123G6	9.44	4.98	3.95	0.17	0.00	0.34
mesenchymal precursor cell - cardiac, donor2	11753-123G7	12.54	7.25	4.03	0.58	0.00	0.23
mesenchymal precursor cell - cardiac, donor3	11754-123G8	14.59	6.23	4.77	0.80	0.13	0.13
mesenchymal precursor cell - cardiac, donor4	11755-123G9	24.71	14.04	6.35	0.95	0.14	1.35
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	24.33	10.53	5.55	1.00	0.14	0.14
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	9.22	9.55	6.59	0.33	0.33	0.66
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	17.30	12.04	8.58	0.69	0.00	0.28
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	13.61	4.89	8.38	1.05	0.35	0.35
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	11.43	6.94	5.51	0.20	0.20	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	7.19	3.59	4.67	0.36	0.72	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	12.62	9.00	4.24	0.31	0.00	0.52
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	8.44	8.44	2.51	0.23	0.23	0.23
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	33.56	15.10	7.13	0.84	0.00	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	13.60	9.12	4.63	0.45	0.00	0.15
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	14.53	4.99	5.43	0.61	0.00	0.26
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	12.15	9.94	6.26	0.37	0.37	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	14.02	12.30	7.15	0.00	0.57	0.00
mesenchymal stem cell line:Hu5/E18	10568-108B1	22.31	12.63	3.37	1.26	0.00	0.84
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	10.96	6.39	2.74	0.46	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	11.25	7.16	7.16	1.02	0.00	0.26
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	9.16	8.38	4.19	0.52	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	8.93	7.09	4.62	0.62	0.31	0.62
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	10.12	7.30	3.77	0.47	0.24	0.24
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	9.82	5.75	3.38	0.68	0.00	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	8.65	4.72	3.93	0.39	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	8.34	4.63	2.78	0.46	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	16.44	7.79	4.04	1.44	0.58	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	11.16	9.37	4.69	1.56	0.45	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	9.61	7.45	5.05	1.44	0.24	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	16.87	14.67	6.60	1.47	0.73	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	8.39	7.05	3.69	0.34	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	8.19	9.42	4.09	1.64	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	14.60	6.87	4.73	0.43	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	8.20	10.94	5.47	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	20.66	0.00	10.33	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	15.59	9.42	6.82	1.62	0.00	0.32
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	10.18	10.18	7.27	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	13.33	8.53	5.86	1.07	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	20.44	6.54	4.09	0.82	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	11.66	7.39	9.33	0.78	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	18.89	6.30	0.00	2.10	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	11.92	5.96	4.97	1.99	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	9.53	9.53	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	19.57	10.08	4.15	1.19	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	12.18	3.66	4.87	2.44	0.00	1.22
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	27.05	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	7.60	9.50	2.53	1.90	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	13.80	14.83	5.86	1.38	0.34	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	21.49	4.30	6.45	0.00	0.00	2.15
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	0.00	11.98	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	6.89	0.00	3.44	3.44	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	6.11	5.30	3.26	0.41	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	7.94	6.36	1.59	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	10.61	5.31	1.77	1.77	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	10.60	7.17	2.81	1.25	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	9.36	6.68	2.67	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	4.73	5.91	2.37	1.18	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	17.98	0.00	5.14	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	15.83	9.64	6.20	0.69	0.00	0.69
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	10.39	9.90	4.45	0.49	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	5.61	3.36	6.73	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	8.90	5.09	6.36	0.00	0.00	0.64
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	4.84	1.61	1.21	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	6.54	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	3.80	2.53	2.53	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	10.32	7.89	1.82	0.00	0.00	0.61
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	0.00	0.00	4.52	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	11.53	4.94	3.29	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	8.14	8.53	5.16	0.60	0.00	0.40
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	7.14	6.81	4.22	0.65	0.00	0.32
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	7.13	3.06	10.19	0.00	0.00	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	47.20	45.65	13.93	2.32	0.00	0.77
mesothelioma cell line:ACC-MESO-1	10493-107B7	50.32	31.42	7.32	0.24	1.18	0.71
mesothelioma cell line:ACC-MESO-4	10494-107B8	73.67	44.48	6.72	1.16	0.23	0.93
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	21.37	4.27	12.82	0.00	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	20.34	14.39	4.32	0.31	0.31	0.41
mesothelioma cell line:Mero-25	10850-111F4	14.07	11.57	0.23	0.23	0.23	0.45
mesothelioma cell line:Mero-41	10851-111F5	35.94	25.18	2.93	1.47	0.24	0.00
mesothelioma cell line:Mero-48a	10852-111F6	17.05	11.07	4.87	0.66	0.44	0.00
mesothelioma cell line:Mero-82	10853-111F7	27.86	20.50	4.73	1.31	0.00	0.00
mesothelioma cell line:Mero-83	10854-111F8	35.92	21.96	9.70	0.68	0.17	0.34
mesothelioma cell line:Mero-84	10855-111F9	7.84	4.80	2.02	0.00	0.00	0.25
mesothelioma cell line:Mero-95	10856-111G1	15.74	11.80	4.76	0.83	0.21	0.41
mesothelioma cell line:NCI-H2052	10847-111F1	2.32	3.31	0.99	0.00	0.00	0.00
mesothelioma cell line:NCI-H226	10846-111E9	15.75	13.39	3.44	0.00	0.00	0.90
mesothelioma cell line:NCI-H2452	10848-111F2	20.84	12.64	4.44	0.85	0.00	0.68
mesothelioma cell line:NCI-H28	10845-111E8	64.63	36.64	12.47	0.25	0.51	0.25
mesothelioma cell line:No36	10857-111G2	21.53	13.37	4.89	0.65	0.33	0.33
mesothelioma cell line:ONE58	10858-111G3	15.17	9.21	2.44	0.00	0.00	0.27
migratory langerhans cells, donor1	11901-125F2	21.88	9.60	1.92	0.38	0.38	0.19
migratory langerhans cells, donor2	11902-125F3	11.48	12.09	1.10	0.12	0.37	0.12
migratory langerhans cells, donor3	11903-125F4	33.92	19.74	3.59	2.51	0.90	0.00
mixed mullerian tumor cell line:HTMMT	10689-109F5	24.81	15.02	3.92	0.65	0.33	0.00
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	13.14	6.36	1.91	0.42	0.00	0.00
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	35.48	28.79	8.75	0.92	0.00	0.46
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	23.79	20.36	4.95	0.57	0.38	0.00
myelodysplastic syndrome cell line:SKM-1	10772-110F7	90.92	51.00	17.37	4.62	0.37	0.92
myeloma cell line:PCM6	10474-106I6	16.41	16.60	10.08	0.79	0.59	0.00
myxofibrosarcoma cell line:MFH-ino	10600-108E6	55.29	34.50	11.67	2.03	0.00	0.00
myxofibrosarcoma cell line:NMFH-1	10684-109E9	22.36	16.28	5.69	1.77	0.20	0.00
nasal epithelial cells, donor1, tech_rep1	12226-129F3	11.48	7.58	4.46	0.11	0.22	0.22
nasal epithelial cells, donor1, tech_rep2	12226-129F3	10.44	7.94	2.13	0.29	0.29	0.00
nasal epithelial cells, donor2	12227-129F4	15.46	12.14	2.21	0.55	0.00	0.00
neuroblastoma cell line:CHP-134	10508-107D4	83.97	43.94	14.49	13.80	0.69	0.69
neuroblastoma cell line:NB-1	10539-107G8	178.11	106.83	60.99	11.23	0.75	1.31
neuroblastoma cell line:NBsusSR	10607-108F4	43.44	23.20	5.06	0.63	0.00	0.42
neuroblastoma cell line:NH-12	10555-107I6	87.40	36.15	12.11	6.89	0.75	0.19
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	83.03	57.41	48.63	10.91	0.24	1.19
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	37.22	20.75	17.42	4.12	0.32	0.32
neuroectodermal tumor cell line:TASK1	10774-110F9	46.09	16.50	23.35	1.41	0.20	0.20
neuroepithelioma cell line:SK-N-MC	10728-110A8	71.21	52.13	22.89	5.09	0.00	1.91
neurofibroma cell line:Hs 53.T	10729-110A9	19.96	15.17	4.52	2.40	0.00	0.27
neutrophil PMN, donor1	12133-128D9	193.37	431.37	0.00	0.00	14.87	0.00
neutrophil PMN, donor2	12137-128E4	13.28	13.28	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	28.41	9.47	0.00	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	215.63	77.96	8.46	10.15	2.03	1.18
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	57.64	36.02	12.81	4.80	0.80	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	17.95	8.34	5.45	0.96	0.00	0.00
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	16.03	6.04	5.26	0.79	0.00	0.00
nucleus accumbens, adult, pool1	10037-101F1	13.03	7.87	8.06	1.69	0.56	0.19
occipital cortex - adult, donor10196	10172-103C1	37.09	18.54	8.24	4.12	2.06	0.00
occipital cortex, adult, donor10252	10163-103B1	32.20	21.47	12.61	2.42	1.88	1.34
occipital cortex, newborn, donor10223	10355-105E4	19.29	9.83	11.28	1.09	0.36	0.00
occipital lobe, adult, donor1	10076-102A4	27.03	14.17	11.02	1.84	1.31	0.52
occipital lobe, fetal, donor1	10073-102A1	64.79	36.90	9.87	6.87	1.72	1.72
occipital pole, adult, pool1	10036-101E9	6.78	3.86	4.49	0.87	0.47	0.08
olfactory region, adult	10195-103E6	27.70	10.32	9.55	2.87	1.91	0.19
optic nerve, donor1	10277-104E7	54.03	18.01	10.01	6.00	2.00	2.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	19.93	17.20	8.20	1.37	0.00	0.23
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	36.68	19.78	10.72	2.20	0.14	0.14
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	38.78	26.08	9.99	1.52	0.17	0.17
oral squamous cell carcinoma cell line:SAS	10544-107H4	32.57	22.64	4.39	0.92	0.12	0.35
osteoclastoma cell line:Hs 706.T	10704-109H2	16.76	13.23	6.17	0.00	0.29	0.88
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	127.07	94.37	21.49	3.74	0.00	2.80
osteosarcoma cell line:HS-Os-1	10558-107I9	45.38	23.96	16.54	1.70	0.21	0.00
ovary, adult, pool1	10020-101D2	39.22	18.34	8.04	4.54	1.14	0.96
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	27.31	19.25	7.70	0.55	0.55	0.18
pancreas, adult, donor1	10049-101G4	8.47	3.76	2.82	0.94	0.00	0.00
pancreatic carcinoma cell line:NOR-P1	10698-109G5	32.71	23.48	8.39	1.40	0.00	0.28
papillary adenocarcinoma cell line:8505C	10437-106E5	20.10	16.52	4.09	2.21	0.00	0.68
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	40.90	37.59	11.59	1.66	0.00	0.33
paracentral gyrus, adult, pool1	10035-101E8	10.62	6.13	6.86	0.46	0.82	0.18
parietal cortex, adult, donor10258	10373-105G4	21.29	7.34	8.07	1.47	0.73	0.00
parietal lobe - adult, donor10196	10171-103B9	26.33	10.35	6.58	0.00	1.88	0.94
parietal lobe, adult, donor10252	10157-103A4	29.36	13.11	9.41	2.28	1.71	0.86
parietal lobe, adult, pool1	10034-101E7	7.84	4.67	6.08	0.70	0.35	0.18
parietal lobe, fetal, donor1	10072-101I9	49.46	15.52	16.49	10.67	0.00	0.00
parietal lobe, newborn, donor10223	10356-105E5	17.95	11.59	10.84	0.75	0.00	0.37
parotid gland, adult	10199-103F1	10.48	8.02	3.08	3.08	0.00	0.62
penis, adult	10200-103F2	28.47	18.26	7.52	6.45	0.54	2.15
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	61.17	36.26	39.42	0.93	0.56	4.09
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	22.87	18.50	9.47	0.29	0.29	0.29
pineal gland - adult, donor10196	10179-103C8	40.64	22.58	10.97	8.39	0.00	0.00
pineal gland, adult, donor10252	10160-103A7	52.11	23.69	24.87	14.81	0.00	1.18
pineal gland, adult, donor10258	10377-105G8	25.71	8.15	13.80	3.14	0.63	2.51
pituitary gland - adult, donor10196	10180-103C9	67.79	32.38	17.20	3.04	2.02	3.04
pituitary gland, adult, donor10252	10162-103A9	81.83	55.25	27.10	9.90	2.08	1.04
pituitary gland, adult, donor10258	10378-105G9	44.26	17.88	20.43	0.85	0.00	0.85
placenta, adult, pool1	10021-101D3	33.22	34.29	13.33	1.18	0.75	0.22
plasma cell leukemia cell line:ARH-77	10840-111E3	40.13	15.63	7.42	1.99	0.79	0.53
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	42.18	30.66	5.91	1.25	0.31	0.62
pons, adult, pool1	10033-101E6	21.69	9.98	10.67	1.98	1.38	1.12
postcentral gyrus, adult, pool1	10032-101E5	8.02	3.75	4.10	0.78	0.44	0.17
promyelocytes/myelocytes PMC, donor1	12132-128D8	202.87	150.58	31.37	6.27	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	11.02	0.00	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	0.00	0.00	0.00	0.00	0.00	11.74
prostate cancer cell line:DU145	10490-107B4	45.45	17.92	10.05	0.87	0.15	0.15
prostate cancer cell line:PC-3	10439-106E7	31.22	18.33	7.80	0.18	0.18	0.18
prostate, adult, pool1	10022-101D4	32.56	20.68	8.98	4.17	1.45	1.36
putamen, adult, donor10196	10176-103C5	38.01	17.94	25.02	1.89	1.18	0.24
putamen, adult, donor10252	10152-102I8	43.14	17.65	9.80	5.88	0.00	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	16.39	10.93	10.93	0.00	0.00	3.28
putamen, adult, donor10258, tech_rep2	10372-105G3	24.64	15.70	17.88	2.66	0.48	0.00
putamen, newborn, donor10223	10365-105F5	18.74	14.24	3.75	4.50	0.00	0.00
rectal cancer cell line:TT1TKB	10469-106I1	70.70	52.08	11.06	4.65	0.58	0.58
rectum, fetal, donor1	10067-101I4	50.08	36.17	15.30	6.95	2.78	1.39
renal cell carcinoma cell line:OS-RC-2	10411-106B6	26.29	18.44	2.12	2.12	0.21	0.42
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	29.41	29.82	1.66	0.00	2.49	1.66
retina, adult, pool1	10030-101E3	18.99	8.55	5.67	2.19	1.09	0.00
retinoblastoma cell line:Y79	10475-106I7	83.92	35.33	22.08	41.83	0.00	0.78
rhabdomyosarcoma cell line:KYM-1	10787-110H4	59.75	23.97	10.45	0.86	0.25	0.49
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	247.74	96.73	52.02	1.69	0.84	1.12
sacrococcigeal teratoma cell line:HTST	10695-109G2	50.02	30.31	11.37	7.58	0.00	0.00
salivary acinar cells, donor1	11771-123I7	22.01	8.42	11.65	2.43	0.16	0.16
salivary acinar cells, donor2	11772-123I8	26.85	10.74	7.71	2.07	0.14	0.28
salivary acinar cells, donor3	11773-123I9	59.58	23.83	16.55	5.96	1.99	0.00
salivary gland, adult, pool1	10093-102C3	5.72	6.29	0.57	0.57	0.57	0.00
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	31.79	18.55	16.27	0.93	0.08	0.08
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	27.74	16.93	12.70	1.53	0.24	0.00
seminal vesicle, adult	10201-103F3	41.27	35.98	12.17	4.76	1.59	1.06
serous adenocarcinoma cell line:JHOS-2	10639-108I9	39.11	30.12	10.69	4.13	1.21	0.73
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	8.30	7.80	3.27	2.52	0.00	0.00
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	16.06	9.03	2.01	3.01	0.00	0.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	35.46	25.25	11.69	1.07	0.00	0.81
signet ring carcinoma cell line:Kato III	10436-106E4	37.14	24.32	2.65	1.66	0.11	0.33
signet ring carcinoma cell line:NUGC-4	10483-107A6	29.42	27.61	7.10	0.90	0.13	0.26
skeletal muscle - soleus muscle, donor1	10282-104F3	53.91	28.37	5.67	7.09	1.42	0.71
skeletal muscle, adult, pool1	10023-101D5	48.21	26.75	7.44	3.00	0.48	1.32
skeletal muscle, fetal, donor1	10066-101I3	24.12	8.04	1.01	4.02	0.00	0.00
skin, adult, donor1	10074-102A2	20.36	13.57	13.57	6.79	0.00	0.00
skin, fetal, donor1	10065-101I2	59.34	35.35	11.36	3.79	0.00	0.00
small cell cervical cancer cell line:HCSC-1	10800-110I8	42.02	16.01	3.00	2.00	0.33	0.00
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	77.54	36.25	29.63	6.62	0.00	0.63
small cell lung carcinoma cell line:DMS 144	10841-111E4	72.09	18.50	14.84	1.73	0.39	1.35
small cell lung carcinoma cell line:LK-2	10541-107H1	71.04	68.24	16.48	9.89	0.33	0.33
small cell lung carcinoma cell line:NCI-H82	10842-111E5	89.59	31.85	26.70	8.04	0.00	1.77
small cell lung carcinoma cell line:WA-hT	10562-108A4	56.44	27.68	10.24	2.40	0.00	0.65
small intestine, adult, pool1	10024-101D6	27.95	23.89	13.97	2.75	0.96	0.96
small intestine, fetal, donor1	10064-101I1	28.75	14.00	12.53	2.95	0.49	0.25
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	19.49	22.05	4.62	5.13	0.00	0.51
smooth muscle, adult, pool1	10048-101G3	19.90	23.78	7.50	2.84	0.78	1.03
somatostatinoma cell line:QGP-1	10781-110G7	32.70	43.15	6.97	2.95	0.54	0.27
spinal cord - adult, donor10196	10181-103D1	26.61	13.31	10.09	1.38	1.38	1.15
spinal cord, adult, donor10252	10159-103A6	34.30	14.98	13.01	3.55	3.15	2.37
spinal cord, adult, donor10258	10369-105F9	22.14	13.14	3.46	2.77	2.08	2.08
spinal cord, fetal, donor1	10056-101H2	48.18	14.64	11.59	5.49	0.00	1.22
spinal cord, newborn, donor10223	10359-105E8	41.79	18.37	6.43	4.59	0.46	2.30
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	22.10	23.15	6.27	1.19	0.15	0.30
spleen, adult, pool1	10025-101D7	32.93	22.25	13.88	4.52	1.43	0.99
spleen, fetal, pool1	10044-101F8	17.16	9.30	6.67	1.59	0.72	0.32
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	39.96	21.84	5.38	1.55	0.41	1.24
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	25.82	18.61	10.06	1.90	0.00	0.38
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	38.44	20.62	9.78	0.70	0.00	0.35
squamous cell carcinoma cell line:T3M-5	10616-108G4	13.68	12.90	5.08	1.17	0.00	0.39
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	17.22	18.23	3.38	2.48	0.23	0.56
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	33.46	17.79	5.08	0.85	0.42	0.00
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	32.15	19.04	8.04	3.81	0.00	0.42
stomach, fetal, donor1	10062-101H8	46.99	42.72	9.61	6.41	0.00	1.07
submaxillary gland, adult	10202-103F4	37.03	28.48	7.41	1.71	3.42	0.00
substantia nigra - adult, donor10196	10178-103C7	0.00	54.27	0.00	0.00	54.27	54.27
substantia nigra, adult, donor10252	10158-103A5	26.38	12.05	9.35	3.53	1.25	1.87
substantia nigra, adult, donor10258	10371-105G2	27.93	12.41	5.69	1.55	0.52	1.03
substantia nigra, newborn, donor10223	10358-105E7	18.37	12.72	7.77	2.12	0.00	0.71
synovial sarcoma cell line:HS-SY-II	10441-106E9	84.37	45.85	30.49	2.75	0.69	0.23
temporal lobe, adult, pool1	10031-101E4	7.38	2.71	5.68	0.68	0.17	0.17
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	55.56	23.50	9.26	6.41	1.42	0.00
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	38.68	18.90	12.75	2.20	0.44	1.32
tenocyte, donor1	11763-123H8	11.87	11.87	6.28	0.00	0.00	0.00
tenocyte, donor2	11765-123I1	9.92	10.30	3.82	0.00	0.00	0.00
tenocyte, donor3	11768-123I4	12.23	4.82	3.71	0.00	0.00	0.00
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	52.01	22.09	11.05	7.31	0.17	0.68
teratocarcinoma cell line:NCR-G1	10798-110I6	42.24	15.11	15.72	10.94	0.00	0.31
teratocarcinoma cell line:PA-1	10807-111A6	48.20	13.64	15.81	3.56	0.46	0.46
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	46.97	28.94	14.85	3.94	0.25	0.63
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	63.91	33.66	26.47	13.24	0.38	0.00
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	68.71	40.13	36.64	20.07	0.22	0.65
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	105.85	29.64	12.05	8.79	0.33	1.63
testis, adult, pool1	10026-101D8	31.57	17.29	102.54	3.76	0.97	0.64
testis, adult, pool2	10096-102C6	21.65	13.08	106.00	0.90	0.45	0.45
thalamus - adult, donor10196	10168-103B6	27.60	11.04	11.04	4.42	1.10	1.10
thalamus, adult, donor10252	10154-103A1	35.48	15.94	12.97	3.13	2.81	2.03
thalamus, adult, donor10258, tech_rep1	10370-105G1	16.94	12.32	9.24	6.16	0.00	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	11.53	6.59	6.26	1.65	0.16	0.49
thalamus, newborn, donor10223	10366-105F6	16.11	9.21	5.18	0.58	0.00	0.58
throat, adult	10209-103G2	36.70	21.47	9.74	3.75	0.75	0.75
throat, fetal, donor1	10061-101H7	42.35	19.81	12.19	4.57	0.61	0.61
thymic carcinoma cell line:Ty-82	10803-111A2	48.89	28.82	11.92	4.77	0.20	0.00
thymus, adult, pool1	10027-101D9	68.40	37.58	12.33	5.96	1.49	1.49
thymus, fetal, pool1	10043-101F7	48.63	27.85	8.21	3.74	1.97	0.94
thyroid carcinoma cell line:KHM-5M	10776-110G2	29.38	12.76	4.79	0.53	0.40	0.27
thyroid carcinoma cell line:TCO-1	10783-110G9	35.90	18.16	13.27	3.35	0.14	0.84
thyroid, adult, pool1	10028-101E1	35.83	14.65	9.70	0.84	1.31	1.59
thyroid, fetal, donor1	10060-101H6	34.28	19.25	10.02	1.85	1.05	0.79
tongue epidermis (fungiform papillae), donor1	10288-104F9	40.04	21.56	6.16	6.16	0.00	0.00
tongue, adult	10203-103F5	25.82	15.35	10.00	1.63	0.00	0.00
tongue, fetal, donor1	10059-101H5	21.28	16.95	7.49	1.58	0.39	0.79
tonsil, adult, pool1	10047-101G2	14.63	10.12	4.41	0.80	1.10	0.30
trachea, adult, pool1	10029-101E2	26.42	17.67	12.84	3.27	0.41	0.65
trachea, fetal, donor1	10058-101H4	44.62	22.31	8.46	3.08	1.54	0.38
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	21.97	12.40	7.09	0.35	0.00	0.35
transitional-cell carcinoma cell line:5637	10418-106C4	70.82	40.22	15.40	5.78	0.41	0.91
transitional-cell carcinoma cell line:JMSU1	10492-107B6	47.79	23.35	13.48	0.94	0.16	0.47
tridermal teratoma cell line:HGRT	10694-109G1	81.81	41.86	7.61	0.00	0.00	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	16.85	12.11	8.80	0.68	0.00	0.17
umbilical cord, fetal, donor1	10057-101H3	16.69	10.43	6.26	0.00	0.00	0.00
uterus, adult, pool1	10100-102D1	21.33	9.21	5.46	2.05	0.51	0.68
uterus, fetal, donor1	10055-101H1	52.73	33.79	11.77	5.63	0.00	0.51
vagina, adult	10204-103F6	32.96	13.57	1.94	0.65	1.29	0.65
vein, adult	10191-103E2	22.36	14.47	8.33	2.19	0.66	0.88
xeroderma pigentosum b cell line:XPL 17	10563-108A5	28.57	13.08	6.14	1.34	0.27	0.53